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The purpose of this study was to examine the effects of attention deficit hyperactivity 
disorder (ADHD) and stimulant medications on concussion measures in physically active 
individuals, and examine differences in practice effects between an un-medicated ADHD 
group and matched controls.  All participants were administered CNS Vital Signs (CNSVS), 
the Balance Error Scoring System (BESS), and the Standardized Assessment of Concussion 
(SAC) on three separate testing sessions (the ADHD group completed session one and two 
on medication and session three off medication), each 7-9 days apart.  The ADHD group had 
diminished scores on measures of overall neurocognitive, psychomotor speed and processing 
speed; these scores improved with medication (p<0.05).Our study suggests that it is 
especially important to obtain a baseline measure in individuals with ADHD, because it is 
difficult to compare scores to normative data and individuals with ADHD should also be 
tested on their medication if possible.   
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Concussion is a common neurological injury in sports, with an estimated 1.6 to 3.8 
million cases occurring each year (Langlois, Rutland-Brown et al. 2006). This may even be 
an underestimate as many concussions go unreported (McCrea, Hammeke et al. 2004).  
Concussion is a complex pathophysiological process within the brain resulting from 
traumatic biomechanical forces, such as a direct blow to the head, neck, face or elsewhere on 
the body, in which the forces are transmitted to the head (McCrory, Meeuwisse et al. 2009).  
The evaluation of concussion involves a multi-faceted approach including: a thorough 
clinical evaluation, assessment of the patient‘s signs and symptoms, measures of postural-
stability, and cognitive or neuropsychological testing (Guskiewicz, Bruce et al. 2004; 
McCrory, Meeuwisse et al. 2009).  Current standards recommend testing athletes on these 
measures prior to athletic participation, in order to serve as a baseline for comparison, in the 
event that the athlete sustains a concussion (Guskiewicz, Bruce et al. 2004; McCrory, 
Meeuwisse et al. 2009).  One reason behind the use of baseline testing is to provide a unique 
measure of an individual‘s performance in the absence of injury to control for ―extraneous 
variables,‖ such as attentional or other disorders that may influence the testing measures 
(Guskiewicz, Bruce et al. 2004).  An example of an attention disorder is attention deficit 
hyperactivity disorder (ADHD), which is a behavioral syndrome primarily characterized by 





Excellence Guidelines, 2006). Attention Deficit Hyperactivity Disorder is commonly 
diagnosed in children, but it often persists into adulthood (Wolf 2001).  In fact, it is 
becoming more and more common for individuals with ADHD and other related disorders to 
attend college, with an estimated 176,000 to 528,000 currently enrolled in universities (Wolf 
2001; Shifrin, Proctor et al. 2009).   
Some studies report a higher rate of injuries in individuals with ADHD, speculating 
that individuals with ADHD are more likely to be inattentive and impulsive and less likely to 
foresee possibly negative consequences of their behaviors (Merrill, Lyon et al. 2009). A 
study by Merrill et al. showed that individuals with ADHD are more susceptible to head 
injuries.  Since this population may be more likely to sustain a head injury, it is essential that 
individuals with ADHD are properly evaluated and treated.  One way to ensure this is to 
make sure athletes with ADHD are administered the recommended baseline testing on 
various clinical measures of concussion.  If an individual sustains a concussion, but does not 
have any baseline scores to use as a comparison, then normative data must be used to assess 
recovery.  This may be common in high schools and other settings where there is not enough 
time or resources to administer baseline testing to all athletes.  Relying on normative data for 
athletes with ADHD could pose a problem, because ADHD may negatively affect some of 
the tasks that are often components of concussion assessment tools.  For example, some 
studies show that ADHD and related disorders may adversely affect working memory 
(Gropper and Tannock 2009; Valera, Brown et al. 2009).  However, very few studies have 
examined the effect of ADHD on commonly used clinical measures of concussion. Attention 
Deficit Hyperactivity Disorder and related disorders have been suggested to adversely affect 





concussion, including scores on verbal memory, visual memory, and working memory 
(Collins, Grindel et al. 1999; Solomon and Haase 2008). 
Several stimulant medications are approved by the Food and Drug Administration for 
the treatment of ADHD in adults (Harpin 2008).  Furthermore, stimulant medications have 
been shown to be an effective treatment for ADHD and are commonly prescribed for that 
purpose.  However, the use of stimulant medication on scores of clinical concussion 
measures is poorly understood (Harpin 2008). It is possible that while on stimulant 
medications individuals with ADHD perform better than when off medication on clinical 
measures of concussion, but no previous studies have assessed this relationship. It has also 
been suggested that two baseline assessments might be necessary in individuals with ADHD, 
one while taking medication, and one without taking medication.  Several studies have 
shown that stimulant medications can have a positive effect on cognition in adults with 
ADHD.  However, some studies show conflicting results.  Advokat et al found that stimulant 
medications may actually impair performance of tasks dealing with adaption, flexibility and 
planning in adults with ADHD (Advokat, Lane et al.).  While it is well established that 
stimulant medications may have a positive effect on various components of cognition, the 
degree of the effect and specific tasks affected is still unclear. 
Clinical outcome measures provide clinicians with valuable information to utilize 
during evaluation and management of concussion and offer quantitative values for use in 
making return to play decisions.  Individuals with ADHD are prone to head injuries; 
however, the effect of ADHD on scores of commonly used concussion assessment tools is 
unclear.  In addition, the effects of the use of stimulant medication on these measures are also 





stimulant medications on commonly used clinical concussion measures, including the CNS 
Vital Signs (CNSVS), the Balance Error Scoring System (BESS), and the Standardized 
Assessment of Concussion (SAC) in physically active individuals.  A secondary purpose was 
to examine differences in practice effects between individuals with ADHD compared to 
matched controls on commonly used clinical concussion measures, including the CNSVS, 




a. Individuals diagnosed with ADHD 
b. Matched controls 
2. Time 
a. Testing Session One 
i. ADHD Group off medication 
ii. Matched controls 
b. Testing Session Two 
i. ADHD Group off medication 
ii. Matched controls 
c. Testing Session Three 
i. ADHD Group on medication 








1. Scores on clinical measures of concussion 
a. CNSVS 
i. Neurocognitive Index (NCI) 
ii. Composite Memory Standard Score 
iii. Verbal Memory Standard Score 
iv. Visual Memory Standard Score 
v. Processing Speed Standard Score 
vi. Executive Function Standard Score 
vii. Psychomotor Speed Standard Score 
viii. Reaction Time Standard Score 
ix. Complex Attention Standard Score 
x. Cognitive Flexibility Standard Score 
b. BESS 
i. Total Error Score 
c. SAC 
i. SAC Total Score 
Research Questions 
1. Within individuals diagnosed with ADHD, is there a significant difference on clinical 
measures of concussion while on medication compared to off medication? 
a. Is there a significant difference in neuropsychological performance, as 
measured by CNS Vital Signs (CNSVS), in individuals with ADHD when on 





b. Is there a significant difference in balance performance, as measured by the 
Balance Error Scoring System (BESS), in individuals with ADHD when on 
stimulant medication compared to off stimulant medication? 
c. Is there a significant difference in mental status, as measured by the 
Standardized Assessment of Concussion (SAC), in individuals with ADHD 
when on stimulant medication compared to off stimulant medication? 
2. Is there a significant difference in scores on clinical measures of concussion between 
individuals with ADHD while on medication and a matched control group? 
a. Is there a significant difference in neuropsychological performance, as 
measured by CNS Vital Signs (CNSVS), between individuals with ADHD 
while on stimulant medication and a matched control group? 
b. Is there a significant difference in balance performance, as measured by the 
Balance Error Scoring System (BESS), between individuals with ADHD 
while on stimulant medication and a matched control group? 
c. Is there a significant difference in mental status, as measured by the 
Standardized Assessment of Concussion (SAC), between individuals with 
ADHD while on stimulant medication and a matched control group? 
3. Is there a significant difference in scores on clinical measures of concussion between 
individuals with ADHD while off medication and matched controls? 
a. Is there a significant difference in neuropsychological performance, as 
measured by CNS Vital Signs (CNSVS), between individuals with ADHD 





b. Is there a significant difference in balance performance, as measured by the 
Balance Error Scoring System (BESS), between individuals with ADHD 
while off stimulant medication and matched controls? 
c. Is there a significant difference in mental status, as measured by the 
Standardized Assessment of Concussion (SAC), between individuals with 
ADHD while off stimulant medication and matched controls? 
4. Is there a significant difference in practice effect between individuals with ADHD off 
their medication compared to matched controls on clinical concussion measures? 
a. Is there a significant difference in practice effect on a neuropsychological 
testing battery, as measured by CNSVS, between individuals with ADHD off 
their medication compared to matched controls? 
b. Is there a significant difference in practice effect on a balance task, as 
measured by the BESS, between individuals with ADHD off their medication 
compared to matched controls? 
c. Is there a significant difference in practice effect on a mental status test, as 
measured by the SAC, between individuals with ADHD off their medication 
compared to matched controls on clinical concussion measures? 
Research Hypotheses 
1. Individuals will demonstrate improved performance on clinical measures of 






a. Individuals with ADHD will demonstrate improved performance on the 
CNSVS when they are on their stimulant medication compared to while off 
their stimulant medication.  
b. Individuals with ADHD will demonstrate improved performance on the BESS 
when they are on their stimulant medication compared to while off their 
stimulant medication.  
c. Individuals with ADHD will demonstrate improved performance on the SAC 
when they are on their stimulant medication compared to while off their 
stimulant medication.  
2. Individuals with ADHD will have diminished performance on clinical measures of 
concussion when on their stimulant medication compared to matched controls. 
a. Individuals with ADHD will have diminished performance on the CNSVS 
when on their stimulant medication compared to matched controls. 
b. Individuals with ADHD will have diminished performance on the BESS when 
on their stimulant medication compared to matched controls. 
c. Individuals with ADHD will have diminished performance on the SAC when 
on their stimulant medication compared to matched controls. 
3. Individuals with ADHD will have diminished performance on clinical measures of 
concussion when off their stimulant medication compared to matched controls. 
a. Individuals with ADHD will have diminished performance on the CNSVS 
when off their stimulant medication compared to matched controls. 
b. Individuals with ADHD will have diminished performance on the BESS when 





c. Individuals with ADHD will have diminished performance on the SAC when 
off their stimulant medication compared to matched controls. 
4. Individuals with ADHD will have a significantly smaller practice effect on clinical 
measures of concussion while off their medication compared to matched controls. 
a. Individuals with ADHD, off their medication, will have a significantly smaller 
practice effect on the CNSVS compared to matched controls. 
b. Individuals with ADHD, off their medication, will have a significantly smaller 
practice effect on the BESS compared to matched controls.  
c. Individuals with ADHD, off their medication, will have a significantly smaller 
practice effect on the SAC compared to matched controls.  
Statistical Hypotheses 
Null Hypotheses 
1. There will be no significant difference in scores on clinical measures of concussion in 
individuals with ADHD while off medication compared to while on medication. 
a. There will be no significant difference in scores on the CNSVS in individuals 
with ADHD while off medication compared to while on medication. 
b. There will be no significant difference in scores on the BESS in individuals 
with ADHD while off medication compared to while on medication. 
c. There will be no significant difference in scores on the SAC in individuals 
with ADHD while off medication compared to while on medication. 
2. There will be no significant difference between scores on clinical measures of 






a. There will be no significant difference between scores on the CNSVS in 
individuals with ADHD while on stimulant medication compared to matched 
controls. 
b. There will be no significant difference between scores on the BESS in 
individuals with ADHD while on stimulant medication compared to matched 
controls. 
c. There will be no significant difference between scores on the SAC in 
individuals with ADHD while on stimulant medication compared to matched 
controls. 
3. There will be no significant difference in scores on clinical measures of concussion in 
individuals with ADHD while off medication compared to matched controls. 
a. There will be no significant difference in scores on the CNSVS in individuals 
with ADHD, when off medication compared to matched controls. 
b. There will be no significant difference in scores on the BESS in individuals 
with ADHD while off medication compared to matched controls. 
c. There will be no significant difference in scores on the SAC in individuals 
with ADHD while off medication compared to matched controls. 
4. There will be no significant difference in the practice effect on clinical measures of 
concussion in individuals with ADHD while off their medication compared to 
matched controls. 
a. There will be no significant difference in the practice effect on the CNSVS in 
individuals with ADHD while off their medication compared to matched 





b. There will be no significant difference in the practice effect on the BESS in 
individuals with ADHD while off their medication compared to matched 
controls.  
c. There will be no significant difference in the practice effect on the SAC in 
individuals with ADHD while off their medication compared to matched 
controls.   
Alternate Hypotheses 
1. There will be a significant difference in scores on clinical measures of concussion in 
individuals with ADHD while off medication compared to while on medication. 
a. There will be a significant difference in scores on the CNSVS in individuals 
with ADHD while off medication compared to while on medication. 
b. There will be a significant difference in scores on the BESS in individuals 
with ADHD while off medication compared to while on medication. 
c. There will be a significant difference in scores on the SAC in individuals with 
ADHD while off medication compared to while on medication. 
2. There will be a significant difference between scores on clinical measures of 
concussion in individuals with ADHD, while on stimulant medication compared to 
matched controls. 
a. There will be a significant difference between scores on the CNSVS in 






b. There will be a significant difference between scores on the BESS in 
individuals with ADHD while on stimulant medication compared to matched 
controls. 
c. There will be a significant difference between scores on the SAC in 
individuals with ADHD while on stimulant medication compared to matched 
controls. 
3. There will be a significant difference in scores on clinical measures of concussion in 
individuals with ADHD, when off medication compared to matched controls. 
a. There will be a significant difference in scores on the CNSVS in individuals 
with ADHD while off medication compared to matched controls. 
b. There will be a significant difference in scores on the BESS in individuals 
with ADHD while off medication compared to matched controls. 
c. There will be a significant difference in scores on the SAC in individuals with 
ADHD while off medication compared to matched controls. 
4. There will be a significant difference in the practice effect on clinical measures of 
concussion in individuals with ADHD while off their medication compared to 
matched controls. 
a. There will be a significant difference in the practice effect on the CNSVS in 
individuals with ADHD while off their medication compared to matched 
controls.   
b. There will be a significant difference in the practice effect on the BESS in 
individuals with ADHD while off their medication compared to matched 





c. There will be a significant difference in the practice effect on the SAC in 
individuals with ADHD while off their medication compared to matched 
controls.   
Assumptions 
1. All participants put forth their full effort on all of the clinical concussion measures on 
all trials. 
2. All participants were truthful and honest in reporting information, such as history of 
previous concussion and use of medication. 
3. Individuals with ADHD were properly evaluated and diagnosed. 
4. Stimulant medications were properly prescribed by physicians. 
5. Participants were taking their stimulant medications as reported during the medicated 
condition and properly refraining from taking their stimulant medications as reported 
during the un-medicated conditions. 
Delimitations 
1. Individuals with a history of three of more concussions, lower extremity injury within 
the past 6 months or one or more concussion(s) within the past 6 months were 
excluded from this study. 
2. Only BESS, CNSVS and SAC were used to assess individuals. 
3. Individuals diagnosed with ADHD were only included if they were currently taking a 
stimulant medication. 
4. Only students at the University of North Carolina at Chapel Hill were used for the 
study. 






1. Information such as history of concussion and medication use was self-reported. 
2. This study only used individuals that were currently taking stimulant medications to 
treat ADHD; results may vary between those on stimulant drugs and those on non-
stimulant drugs. 
3. This study only used participants diagnosed with ADHD. The results may vary 
between those with ADHD and other diagnosed attention deficits.  
Definition of Terms 
1. ADHD- a behavioral syndrome primarily characterized by hyperactivity, impulsivity 
and inattention, as diagnosed by a physician at least 3 years ago. 
2. Stimulant medication- a drug that increases the activity of the nervous system that has 
been prescribed by a physician for the treatment of ADHD; these can include 
immediate release methylphenidates (such as Ritalin), sustained release 
methylphenidate (such as Concerta XL), dexamfetamine (such as Dexedrine) and 
atomoxetine (such as Strattera) 
3. Physically active- has consistently participated in at least 30 minutes of 
cardiovascular and/or resistive training at least four times per week for the past five 
months 
4. CNS Vital Signs (CNSVS) (Appendix 1) - a series of computerized 
neuropsychological tests that can detect changes in neuropsychological performance 
over time, allowing for contributions to the assessment of concussion. The CNSVS 





a. Neurocognitive Index (NCI)- average of the domain scores which provide 
an assessment of overall neurocognitive status 
i. The Neurocognitive Index is calculated by taking the average of all 
of the domain scores. 
b. Composite Memory Domain Score- sum of scores from verbal and visual 
memory tests, which provide information about the ability to recognize 
and remember words and geometric figures. 
i. This score is calculated using the following equation: Verbal 
Memory (VBM) Correct Hits Immediate + VBM Correct Passes 
Immediate + VBM Correct Hits Delay + VBM Correct Passes 
Delay + Visual Memory (VIM) Correct Hits immediate + VIM 
Correct Passes Immediate + VIM Correct Hits Delay + VIM 
Correct Passes Delay 
c. Verbal Memory Domain Score- comprised of results from verbal memory 
test, which measures the ability to recognize and remember words. 
i. This score is calculated using the following equation: VBM 
Correct Hits Immediate + VBM Correct Passes Immediate + VBM 
Correct Hits Delay + VBM Correct Passes Delay  
d. Visual Memory Domain Score- comprised of results from visual memory 






i. This score is calculated using the following equation: VIM Correct 
Hits immediate + VIM Correct Passes Immediate + VIM Correct 
Hits Delay + VIM Correct Passes Delay 
e. Processing Speed Domain Score- results of symbol digit coding test, 
which measures the ability to automatically perform relatively simple 
cognitive tasks. 
i. This score is calculated using the following equation: Symbol 
Digit Coding (SDC) Correct Responses-SDC Errors 
f. Executive Function Domain Score- results of shifting attention test, which 
measures the ability to manage multiple tasks simultaneously. 
i. This score is calculated using the following equation: Shifting 
Attention Test (SAT) Correct Responses-SAT Errors 
g. Psychomotor Speed Domain Score- comprised of results from finger 
tapping test and correct responses from symbol digit coding test; score 
indicates ability to recognize and process information. 
i. This score is calculated using the following equation: Finger 
Tapping Test (FTT) Right Taps Average + FTT Left Taps Average 
+ SDC Correct Responses 
h. Reaction Time Domain Score- comprised of results from stroop test, 
which measures the ability to react to a simple, but increasingly difficult 





i. This score is calculated using the following equation: [Stroop Test 
(ST) Complex Reaction Time Correct + Stroop Reaction Time 
Correct] /2 
i. Complex Attention Domain Score- comprised of errors on stroop test, 
shifting attention test and continue performance test, which is indicative of 
the ability to maintain focus and quickly but accurately perform tasks. 
i. This score is calculated using the following equation: Stroop 
Commission Errors + SAT Errors + CPT Commission Errors + 
CPT Omission Errors 
j. Cognitive Flexibility Domain Score- comprised of results from shifting 
attention test and errors on stroop test; assesses the ability to adapt and 
react to a continuously changing and increasingly difficult set of 
directions. 
i. This score is calculated using the following equation: SAT Correct 
Responses – SAT Errors – Stroop Commission Errors 
5. Balance Error Scoring System (BESS) (Appendix 2) - an objective assessment tool 
developed to assess postural stability following concussion in which three different 
stances (double leg, single leg and tandem stance) are completed twice (once on a 
firm surface and once on a foam surface), for a total of six twenty second trials 
(Guskiewicz 2003; Hunt, Ferrara et al. 2009). Errors are totaled for each trial and 
include lifting hands off of iliac crests, opening eyes, stepping/tumbling/falling, 
moving hip into greater than thirty degrees of flexion or abduction, lifting forefoot or 





a. Firm Condition Score- total number of errors during the three trials 
performed on the firm surface. 
b. Foam Condition Score- total number of errors during the three trials 
performed on the foam surface. 
c. BESS Total Score- total number of errors during all six trials (Firm Error 
Score + Foam Error Score). 
6. SAC (Appendix 3) - a mental status examination designed to detect mild brain injury and 
concussion. The SAC takes about five minutes to administer and contains four component 
scores as well as a SAC total score (McCrea, Kelly et al. 1998) 
a. Orientation Score- one point is awarded for the correct response to each of 
the following: the day of the week, month, date, year and time of day 
within one hour; the maximum score is 5 points. 
b. Immediate Memory Score- a five-word list is read for immediate recall 
and is repeated for three trials, one point is given for each correct word 
remembered for a total possible 15 points. 
c. Concentration Score- the individual is asked to repeat strings of digits that 
increase in length from three to six numbers in reverse order and to recite 
the month of the year in reverse order; a total of 5 points can be earned in 
this section. 
d. Delayed Recall- the individual is asked to recall the original five words 
from the immediate memory section and is awarded one point for each 





e. SAC Total Score- the sum of the orientation, immediate memory, 
concentration and delayed recall scores; highest possible score is 30. 
  
      
CHAPTER II 
REVIEW OF LITERATURE 
Introduction 
Concussion, a form of mild traumatic brain injury (MTBI), is a common neurological 
injury that occurs in all levels of athletic participation.  An estimated 1.6 to 3.8 million 
people sustain a concussion each year (Echemendia and Julian 2001; Collie, Makdissi et al. 
2006).  The true rate of injury could be much higher because many concussions may go 
unreported (McCrea, Hammeke et al. 2004).  This is concerning because athletes who do not 
report concussions and return to play increase their risk of a recurrent and possibly 
catastrophic injury (McCrea, Hammeke et al. 2004).  Also, the potential for long term effects 
of repetitive MTBIs has recently been recognized (Bailes and Hudson 2001).  Therefore, the 
term ―ding‖ should not be used to describe MTBIs, because it does not convey the 
seriousness of the potential long-term effects of injury to the brain (Bailes and Cantu 2001; 
McCrory, Meeuwisse et al. 2009).   
In order to properly evaluate and manage concussion, baseline clinical measures are 
taken prior to the beginning of an athletic season and repeated if an individual sustains a 
concussion.  Clinical measures taken following a concussion are then compared to baseline 
scores to ensure a recovery of balance, neurocognition and symptoms before the individual 
returns to play (Guskiewicz, Bruce et al. 2004).  Ensuring that clinical measures of 





post-injury scores, which is needed for the proper evaluation and management of concussion.  
One way to increase the validity and reliability of concussion measures is to control for 
extraneous variables, such as ADHD.  Little is known about the effect of ADHD on baseline 
and post-injury clinical measures, making it difficult to control for this variable during 
evaluation.  
Colleges and universities have a growing population of individuals with ADHD,with an 
estimated 176,000 to 528,000 currently enrolled (Wolf 2001; Shifrin, Proctor et al. 2009). It 
is important to understand the influence of ADHD and use of stimulant medication on 
common clinical measures of concussion, in order to properly evaluate and manage 
concussions in this population.  This is especially important since individuals with ADHD 
have been reported to be more prone head injuries (Merrill, Lyon et al. 2009).   
Sport-Related Concussion 
Definition 
Concussion is a complex pathophysiological process which affects the brain and is 
caused by traumatic biomechanical forces, such as a direct blow to the head, neck, face or 
elsewhere on the body, in which the forces are transmitted to the head (McCrory, Meeuwisse 
et al. 2009).  Concussion typically results in a temporary decrease in neurological function 
and the development of post-concussive symptoms that may or may not include a loss of 
consciousness.  Acute evaluation of concussions should focus on ruling out life threatening 
or more severe injuries, such as a cervical spine injury or an intracranial hematoma.  Once 
life-threatening injuries are ruled out, the evaluation should involve repeated evaluations on a 
multitude of measures, beginning with a sideline evaluation and continuing throughout full 





(McCrory, Meeuwisse et al. 2009).  Unfortunately, there is no way to predict how long it will 
take an individual to recover from a concussion.     
Several grading scales and return to play guidelines for guiding the management of 
concussion exist, but none of them are universally accepted as the ―gold standard‖.  Many of 
the grading scales associate the most severe injuries with a loss of consciousness 
(Guskiewicz, Bruce et al. 2004).  However, it is widely accepted that loss of consciousness is 
not necessarily related to the recovery time following a concussion (Guskiewicz, Bruce et al. 
2004).  Therefore, current literature suggests waiting to assign a grade to a concussion until 
after all signs and symptoms have resolved, or simply not assigning a grade to a concussion 
at all (Guskiewicz, Bruce et al. 2004).  Instead of focusing on grading scales, it is important 
for clinicians to focus on signs and symptoms, clinical evaluation and clinical measures of 
concussion, and to treat each case individually. 
Pathophysiology 
Sport related concussion is often the result of a direct blow to the head by another 
participant or object.  Sudden acceleration or deceleration of the head can result in 
compressive, shear and tensile stress to cerebral tissue, leading to a diffuse injury with one of 
two mechanisms (linear impact or rotational/angular impact).  Acceleration-deceleration 
injuries usually occur when an individual is moving and comes into contact with a stationary 
object.  These injuries cause shifting of cerebral tissue within the cranium, which may cause 
microscopic tearing of small vessels and capillaries, resulting in localized bleeding and 
hematoma formation (Bailes and Cantu 2001).   
Brain injuries that occur in sport can be classified as either focal or diffuse.  Focal 





vessels, typically resulting in macroscopic lesions such as cortical or subcortical brain 
contusions and intracerebral hematomas (Bailes and Cantu 2001).  Diffuse brain injuries vary 
in intensity from mild to severe, and are often caused by rotational forces from a direct or 
indirect blow.  Diffuse injuries often result in shearing of white matter within the cortex to 
the midbrain and brainstem, and are not visible in diagnostic images (Bailes and Cantu 
2001). 
Injuries to the brain result in a neurometabolic cascade.  Extracellular potassium 
concentrations rise because neurotransmitters, such as glutamate, open ionic channels 
immediately after brain injury (Bailes and Cantu 2001; Giza and Hovda 2001).  The sodium-
potassium pump requires more adenosine-triphosphate than usual, causing an increase in the 
glucose metabolism.  The lack of glucose availability is most likely explanation for the 
brain‘s vulnerability to subsequent injury immediately following a previous head injury 
(Giza and Hovda 2001).  Other physiological events associated with head injury include the 
generation of lactic acid, decrease in intracellular magnesium, production of free radicals, 
activation of inflammatory responses and alterations in neurotransmission (Giza and Hovda 
2001).These physiologic changes present themselves clinically as post-concussive signs and 
symptoms, deficits in postural stability and neuropsychological deficits.  
Signs and Symptoms 
 
Signs and symptoms of concussion range from obvious signs, such as altered levels of 
consciousness, to milder self-reported symptoms, such as a headache.  Concussion has been 
defined as an injury that involves an acceleration-deceleration mechanism in which a blow to 





balance problems, feeling ‗slowed down‘, fatigue, trouble sleeping, drowsiness, sensitivity to 
light or noise, loss of consciousness, blurred vision, difficulty remembering, or difficulty 
concentrating‖ (1997).  Signs and symptoms play a vital role in the evaluation of concussion 
and return to play decisions (McCrory, Meeuwisse et al. 2009).  Therefore, one commonly 
used clinical measure of concussion is a Graded Symptoms Checklist (GSC).  A GSC allows 
the athlete to denote the frequency and/or severity of symptoms, typically utilizing some type 
of Likert scale.  The responses are then summed to obtain a total symptom score, which can 
be used as a measure of the severity of the concussion and help track recovery.  While signs 
and symptoms are a vital component to the evaluation and management of concussion, other 
factors must also be taken into account.  
Evaluation and Management  
Clinicians can refer to the NATA position statement, the Consensus Statement on 
Concussion in Sport: 3
rd
 International Conference on Concussion in Sport, and other 
relevant literature for guidelines in evaluating and managing concussion.  Acute management 
of concussions should include monitoring individuals for deterioration throughout the first 
few hours following the injury (McCrory, Meeuwisse et al. 2009).  In addition, a GSC should 
be administered.  Once an individual is symptom free, they should be reassessed on all 
concussion assessment tools. This allows for comparison of post-injury scores to baseline 
scores, providing a more comprehensive depiction of injury status and guiding return to play 
decisions.  Evidence suggests that the use of a single concussion assessment tool has a 
sensitivity of 43 to 80%, whereas the use of a combination of tests could increase the 
sensitivity to greater than 90% (Broglio, Ferrara et al. 2007). A general consensus is that a 





cognitive, postural-stability and neuropsychological testing (Guskiewicz, Bruce et al. 2004).  
No one test should supersede the results of another test or evaluation.   
Clinical Measures of Concussion 
Mental Status 
Tests of mental status evaluate the immediate neurocognitive effects of concussion, 
such as alterations in short-term or working memory.  Several methods exist for evaluating 
the mental status and cognitive function of a concussed athlete.  An example of a mental 
status test is the Standardized Assessment of Concussion (SAC).  The SAC is a brief pencil 
and paper test that was designed for quick and easy application in the clinical or on-field 
setting.  It takes about five minutes to administer and includes measures of orientation, 
immediate memory, concentration, delayed recall and a SAC total score.  A neurological 
screening, documentation of duration of loss of consciousness (if applicable) and presence of 
retrograde or anterograde amnesia are also included on the SAC.  There are 30 possible 
points for the SAC total score and lower scores indicate cognitive impairment.  There are 
three versions of the SAC (Form A, Form B and Form C), which are utilized for retesting 
following concussions, in order to minimize the practice effect.   
The validity and reliability of the SAC has been examined and it has been found to be 
both valid and reliable (Valovich, Perrin et al. 2003).  However, it is possible that scores on 
the SAC could be affected by ADHD.  Several studies have shown that ADHD negatively 
affects working memory, which is one of the key components measured in the SAC (Hervey, 
Epstein et al. 2004; Martinussen, Hayden et al. 2005; Willcutt, Pennington et al. 2005).  In 
addition, the effect of stimulant medications on working memory in adults with ADHD is 






Deficits in postural stability have been noted following concussion (Guskiewicz, Ross 
et al. 2001).  Several methods for evaluating postural stability following concussion exist.  
Initially, simple examinations such as Rhomberg and stork stand were commonly used for 
evaluating postural stability following concussion.  Currently, common methods for 
evaluating postural stability include the Balance Error Scoring System (BESS) and the use of 
force plates.  The BESS involves six twenty second balance trials, including a double-leg, 
single-leg and tandem stance on both a firm and foam surface.  Individuals are given one 
point for each error that they have during each trial. Errors include lifting hands off of iliac 
crests, opening eyes, stepping/tumbling/falling, moving hip into greater than thirty degrees of 
flexion or abduction, lifting forefoot or heel and remaining out of the test position for longer 
than five seconds.  The BESS has been shown to be both valid and reliable, and has shown 
good concurrent validity, when compared to forceplate measures (Hunt, Ferrara et al. 2009).  
Some benefits of the BESS are that it is cost-effective and can be completed on the sideline 
following a concussion.   
There is not a lot of data that exists concerning the effects of ADHD and stimulant 
medications used to treat ADHD on postural stability.  There are a few studies that have 
shown that ADHD affects motor control (Leitner, Barak et al. 2007; Fliers, Vermeulen et al. 
2009).  In addition, another study by Shun et al showed that there was a significant difference 
in balance performance between an ADHD and control group.  Furthermore, one study 
showed that that a stimulant drug used for the treatment of ADHD, helped decrease the 
variability in stride lengths during gait that was noticed in an ADHD group (Leitner, Barak et 





ADHD, it is still unclear whether or not adults with ADHD typically have balance or postural 
control deficits.   
Neuropsychological 
The use of neuropsychological tests, especially computerized tests, for the assessment 
of concussion continues to increase. Some advantages of computerized neuropsychological 
tests include ease of administration, shorter time period needed for testing and presence of 
multiple forms of tests, in order to minimize practice effects.  There are several different 
types of computerized neuropsychological test batteries used by clinicians to assess 
concussions, including the Immediate Post-Concussion Assessment and Cognitive Testing 
(ImPACT), Automated Neuropsychological Assessments Matrix (ANAM), CogSport, 
Concussion Resolution Index and CNS Vital Signs (CNSVS).  CNSVS is a newer test battery 
consisting of a series of computerized neuropsychological tests that can detect changes in 
performance over time, allowing for assistance in the evaluation of concussion.  Results 
include scores for the following clinical domains: neurocognitive index, composite memory, 
verbal memory, visual memory, processing speed, executive function, psychomotor speed, 
reaction time, complex attention and cognitive flexibility.  Performance on CNSVS has been 
shown to be related to the severity of brain injury and rate of recovery (Gualtieri and Johnson 
2006).  CSNVS has also been shown to be reliable (Gualtieri and Johnson 2006).    
Many of the various neuropsychological test batteries utilize similar tasks.  However, 
some sections of CNSVS are not included in most other neuropsychological test batteries.  
For example, tasks such as the Continuous Performance Test (which measures sustained 
attention) and the Shifting Attention Test (which measures the ability to switch from one 





components that should be examined post-concussion, especially in individuals with ADHD.  
Studies have shown that executive functions, such as focus, are impaired in many individuals 
with ADHD.  Focus is an executive function that is utilized in tasks involving sustaining 
focus and shifting focus to tasks (Brown 2008). 
It is important that the clinical measures of concussion have been found to be valid 
and reliable, because there is a chance that they may need to be administered multiple times 
to the same athlete over a short period of time.  Since a learning or practice effect may exist, 
individuals should not be administered follow up testing until they are symptom free and 
scores must return to at or above baseline before return to play is considered.  Comparing 
post-injury scores on clinical measures of concussion to baseline scores gives clinicians a 
quantitative measure for making return to play decisions.   
Return to Play Following Concussion 
 While no specific return to play guidelines for concussions have been established, a 
basic progression has been agreed upon.  Once an individual is completely symptom free 
(determined using a graded symptom scale or symptoms checklist), he or she should be re-
administered concussion assessment tools.  Follow-up assessments should be performed both 
at rest and after exertional maneuvers (Guskiewicz, Bruce et al. 2004).  Baseline measures 
for neuropsychological and postural stability tests should be conducted prior to the beginning 
of the athletic season, to determine ―normal‖ scores for each individual (Guskiewicz, Bruce 
et al. 2004).  The post-injury assessments can then be compared to the baseline assessment to 
determine that the individual has returned to a pre-injury status.   
 Once an individual is symptom free at rest and at exertion and clinical measures 





activity.  The individual should avoid activities that place them at an increase risk of 
sustaining a recurrent head injury for the first few days back to activity (Guskiewicz, Bruce 
et al. 2004).  The individual should also be educated on the signs and symptoms of 
concussion and told to notify the sports medicine professional and discontinue activity if any 
of these signs and symptoms return.  If the individual is able to perform exertional activities 
without any return in signs and symptoms, then he or she should be reassessed on the clinical 
measures of concussion.  Once these measures return to baseline and the individual is able to 
perform activities symptom free, he or she can then be returned to full activity (Guskiewicz, 
Bruce et al. 2004).  The athlete should also be taught prevention techniques before returning 
to play as individuals who sustain a head injury are more likely to sustain additional head 
injuries in the future (McCrory, Meeuwisse et al. 2009). 
Injury Risks 
 Certain individuals are thought to be at an increased risk of sustaining a head injury.  
For example, individuals with ADHD have been shown to be at a greater risk of sustaining a 
head injury than the general population (Merrill, Lyon et al. 2009). Individuals with ADHD 
are thought to be at least 1.5 times greater than those without ADHD to injure themselves 
and are at a significantly higher risk of suffering a serious injury, such as a fracture, 
intracranial injury or internal injury (Merrill, Lyon et al. 2009).  Furthermore, it has been 
shown that individuals with ADHD are significantly more likely to be injured while riding a 
bicycle, driving a car, to receive head injuries and to be hospitalized for unintentional injuries 
(Merrill, Lyon et al. 2009).  Individuals with ADHD are more likely to be inattentive and 
impulsive and therefore less likely to foresee possibly negative consequences of their 





fact that individuals with ADHD are at a greater risk for injury and should instruct them on 
proper injury prevention techniques.  Furthermore, since this population is more likely to 
sustain a head injury, it is essential that individuals with ADHD are properly evaluated and 
treated for head injuries.  Clinicians who work with patients with ADHD should be familiar 
with the syndrome in order to provide the proper care. 
Attentional Deficit Hyperactivity Disorder 
Definition 
ADHD is a behavioral syndrome primarily characterized by hyperactivity, 
impulsivity and inattention (National Institute for Health and Clinical Excellence Guidelines, 
2006).  Individuals can possess all of the symptoms, or they can be characterized as 
predominantly hyperactive/impulsive and impulsive, or predominantly inattentive (National 
Institute for Health and Clinical Excellence Guidelines, 2006).  Initially, ADHD was 
associated with disruptive behavior during childhood that usually subsided in early 
adolescence.  However, recent research has caused a major shift in the view of ADHD and it 
has begun to be described as a disorder of ―cognitive function‖ (Brown 2008; Gropper and 
Tannock 2009).  It has been shown that many individuals with ADHD have more difficulty 
with focusing their attention on necessary tasks and effectively using working memory, than 
they do with behavioral problems (Brown 2008).  In addition, impairments associated with 
ADHD may not become apparent until late adolescence or early adulthood, when individuals 
are required to manage a wide range of tasks themselves (Brown 2008).  Further research is 






 The etiology and physiology of ADHD are still poorly understood. Several studies 
have identified possible factors associated with the development of ADHD, including genetic 
effects, environmental effects, and structural abnormalities of the brain (Hay, Bennett et al. 
2007).  Genetics may play an effect on the incidence of ADHD, because there is a higher 
occurrence in monozygotic twins than dizygotic twins (Reynolds, 2008).  In addition, 
siblings of hyperactive children are twice as likely to have the disorder (Wender and 
Rothkegel 2000).  Although there is some evidence that genetics may play a role in ADHD, 
strong evidence does not exist.   
 Similarly, there is some small evidence that several environmental factors may be 
linked with ADHD.  Food additives, colorings, preservatives and sugar have been examined 
and found to be possible causes of hyperactive behavior (McCann, Barrett et al. 2007).  
Psychosocial factors may also play a role in ADHD, such as prolonged emotional distress, 
stressful psychic events and anxiety-inducing events (Brock, et al., 2009).  In fact, not only 
do these factors seem to be related to the cause of ADHD, they all seem to be involved with 
the exacerbation of the disorder (Brock et al, 2009).  There is little research in this area and 
no strong evidence to support the association of any one environmental factor with ADHD. 
 Finally, there is some evidence to suggest that structural abnormalities of the brain 
may be the cause of ADHD.  Several neurotransmitters have been associated with ADHD. 
Furthermore, at a younger age, there has been some correlation between 
electroencephalogram (EEG) patterns and ADHD suggesting that there may be a relationship 
between the structure of the brain and ADHD.  Most research in this area has examined 
specific characteristics of the brain and their associations with ADHD, focusing on inhibitory 





systems that innervate these circuits (Halperin and Schulz 2006).  The NIH-Centers for 
Disease Control stated that while research suggests a central nervous system basis for 
ADHD, more research is needed in order to firmly categorize ADHD as a brain disorder 
(NIH, 2000).  While some progress has been made in determining the pathophysiology of 
ADHD, much more research is needed.  This research is vital as it guides the diagnosis and 
management of ADHD and may help explain the signs and symptoms of the disorder. 
Signs and Symptoms 
 There is some debate about the onset of signs and symptoms of ADHD.  Some 
believe that signs and symptoms must have an onset of seven years of age or earlier, while 
others believe that signs and symptoms may not become evident until late adolescence or 
even early adulthood (Brown 2008).  Recently, the general consensus in diagnosis of ADHD 
has been that the age of onset should not supersede significant impairment and other 
diagnostic criteria (Brown 2008).  In fact, a later age of onset makes sense because cognitive 
functions that are affected by ADHD are the slowest to mature (Brown 2008).  In addition, 
individuals may not notice the signs or symptoms of ADHD until they are required to make 
decisions and manage their time on their own. 
Signs and symptoms of ADHD can typically be broken into three different categories: 
inattention, hyperactivity and impulsivity.  Individuals who are inattentive typically report 
symptoms of not giving close attention to details, making careless mistakes in schoolwork or 
work, trouble paying attention to necessary tasks, inability to listen when spoken to, inability 
to follow instructions or failure to complete tasks, difficulty organizing activities, avoidance 
of schoolwork or homework, frequent loss of important objects, being easily distracted, or 





developmental level (CDC 2000). Individuals with hyperactive tendencies present with 
symptoms of fidgeting with hands or feet, squirming in seat, often getting up from seat when 
expected to remain seated, often running or climbing when it is not appropriate, trouble 
playing or enjoying leisure activities quietly, inability to sit still, and excessive talking (CDC 
2000).  Individuals who are characterized as impulsive may blurt out answers before 
questions have been finished, have trouble waiting his/her turn, or interrupt or intrude on 
others (CDC 2000). Clinicians must recognize that ADHD presents with a variety of signs 
and symptoms. 
Signs and symptoms of ADHD often vary depending on situations.  For example, 
individuals with ADHD may report the ability to focus their attention on a few specific tasks 
that they truly enjoy, such as playing a sport (Brown, 2008).  However, they are unable to 
focus on other necessary tasks, such as completing school work.  There is actually a chemical 
cause behind this variability in symptoms.  When individuals are confronted with tasks that 
they find appealing, the brain provides chemical stimulus that activates the necessary 
executive functions (Brown 2008). 
Many of the signs and symptoms associated with ADHD are also common post-
concussive symptoms.  This creates difficulty in differentiating between symptoms that were 
present prior to injury and those induced by injury in athletes with ADHD.  For example, a 
common symptom of concussion is difficulty concentrating, which is also a hallmark 
symptom of ADHD. In addition, working memory, which is a main component of several 
neuropsychological tests used to assess concussion, is often impaired in individuals with 





time distinguishing whether the individual‘s difficulty concentrating, trouble with working 
memory, or other observed deficits are a result of a concussion or due to ADHD.   
Diagnosis 
Currently two main diagnostic criteria for ADHD are being used.  The International 
Classification of Mental and Behavioural Disorders 10
th
 revision (ICD-10), a relatively 
narrow diagnostic category focusing on individuals with more severe impairment, is one of 
the tools being used.  The Diagnostic and Statistical Manual of Mental Disorders 4
th
 edition 
(DSM-IV) is also commonly used and utilizes a broader definition of ADHD with several 
subtypes.  These diagnostic tools include behavior checklists. The DSM-IV utilizes an 
ADHD rating scale (Appendix 4) which determines a diagnosis of ADHD based on the 
presence of either 6 or more symptoms of inattention or 6 or more symptoms of 
hyperactivity-impulsivity that have been present for at least 6 months and have been 
disruptive and inappropriate for developmental level  (Brimble 2009).  In addition, some of 
the impairments must be present in two or more settings and there must be evidence of 
significant impairment in social, school or work functioning (CDC 2000).  Finally, the 
symptoms cannot be due to another mental disorder (CDC 2000).  The DSM-IV identifies 
three subtypes of ADHD including predominantly inattentive, predominantly hyperactive-
impulsive and combined.  The predominantly inattentive diagnosis is characterized by having 
six or more inattention symptoms, but less than six hyperactivity-impulsivity symptoms.  The 
predominantly hyperactive-impulsivity type is characterized by six or more hyperactive-
impulsivity symptoms, but less than six inattention symptoms.  The combined type is 





While criteria exist for the diagnosis of ADHD, they should not be used as the sole 
tool for diagnosis.  Not only should the assessment include a self-report of symptoms, but it 
should involve the report of symptoms observed by the individual‘s parent or another close 
relative or friend (DuPaul, et al., 2009).  In addition, it should involve a direct assessment of 
attention and impulsivity (DuPaul, et al., 2009).  Furthermore, neuropsychological tests may 
be used to help identify deficits in executive function.  Once the proper diagnosis is made, 
the appropriate treatment plan should be developed.    
Treatment 
Several different treatment types exist for the management of ADHD.  The majority 
of therapies can be categorized as behavioral therapy, non-stimulant medication or stimulant 
medication.  Behavioral therapy involves the modification of daily habits in order to help 
control the signs and symptoms of ADHD.  For example, healthcare professionals may 
suggest using a food and drink log to determine any possible relationships between diet and 
hyperactive behavior (National Institute for Health and Clinical Excellence Guidelines, 
2006).  If a relationship exists, then those foods and/or drinks are essentially removed from 
the individual‘s diet.  Behavioral therapy also includes education programs with management 
strategies, such as using positive reinforcement for good behavior and negative consequences 
for poor behavior (National Institute for Health and Clinical Excellence Guidelines, 2006).  If 
behavioral therapy is not successful in treating an individual‘s ADHD, then individuals often 
turn to medication to help relieve their signs and symptoms.   
Medication 
Stimulant medications are the most commonly prescribed medications for college 





been shown to be an effective treatment for ADHD and several stimulant medications have 
been approved by the Food and Drug Administration for the treatment of ADHD in adults 
(Brown 2008).  The most commonly used stimulants include immediate release 
methylphenidates (such as Ritalin), sustained release methylphenidate (such as Concerta 
XL), dexamphetamine (such as Dexedrine) and atomoxetine (such as Strattera) (Harpin 
2008).  Healthcare professionals must be careful when prescribing stimulant medications for 
ADHD.  Often times, these medications do not follow the guidelines for patients and the 
effective dosing is not consistently related to age, weight or symptom severity (Brown 2008).  
Therefore, patients should be started on a minimal dose and then gradually increase until the 
optimal dose is identified.  Patients should be asked about how the medication works during 
different times of the day and during different tasks.  The timing of medication should also 
be considered as different patients need their medication to be most effective at different time 
periods throughout the day and sometimes varying times from day to day.  Prescription of 
stimulant medications should involve a comprehensive evaluation and follow up regarding 
the effectiveness of medication. 
Some research has been conducted examining the effects of stimulant medication on 
clinical measures of ADHD, with varying results (Froehlich, McGough et al. ; Sprafkin, 
Mattison et al.).  However, no previous research studies have determined whether individuals 
with ADHD should be administered baseline clinical measures of concussion while on or off 
their medication. This could potentially make a difference on the interpretation of scores and 
ultimately affect evaluation and management of concussion.  Stimulant medications have 
been shown to produce a significant improvement in symptom severity, which could lead to 





medications increased performance on a neuropsychological task in individuals with ADHD 
(Mikami, Cox et al. 2009).  Another possible interaction that stimulant medication could 
have on clinical measures of concussion is the overlap between common side effects of 
stimulant medications and signs and symptoms of concussion.  Some overlapping symptoms 
include irritability, vomiting and headache (Cowles 2009; Mikami, Cox et al. 2009).   
Effect of ADHD on Cognition 
Attentional Deficit Hyperactivity Disorder has been shown to have an effect on 
executive functioning.  Deficits in executive function can affect a wide range of cognitive 
functions that are critical for managing the multiple tasks of daily life (Brown 2008).  Brown 
identifies six executive functions that are typically impaired in individuals with ADHD.  One 
of these functions is activation, which involves organizing tasks and materials.  An individual 
with impaired activation may report excessive procrastination (Brown 2008).  Focus is also 
often affected and deficits may be described as being easily distracted or constantly having to 
re-read portions of a book for the passage to become meaningful (Brown 2008).  Individuals 
also have difficulty with effort, which involves regulating alertness, sustaining effort and 
processing speed (Brown 2008).  Emotional abnormalities are also described in which 
individuals have difficulty managing frustration, anger, disappointment and other emotions 
(Brown 2008).  Finally, difficulty in monitoring and regulating self-action may be described 
and individuals may have difficulty using working memory and accessing recall (Brown 
2008). 
Several studies have also shown the adverse effect of ADHD on cognitive tasks that 
incorporate visual, verbal, and working memory (Valera, et al., 2009; Collins, et al., 1999; 





individuals to retain and manipulate information for several seconds, has been shown to be 
impaired in individuals with ADHD (Hervey, Epstein et al. 2004; Martinussen, Hayden et al. 
2005; Willcutt, Pennington et al. 2005).  Although executive function deficits that can be 
detected using neuropsychological tests are often associated with ADHD, they do not always 
exist.  Therefore, neuropsychological tests should not be used as the sole tool for the 
diagnosis of ADHD.   
Effect of ADHD on Balance 
 It is also possible that ADHD could have a negative effect on balance.  Some studies 
have shown that ADHD is associated with motor problems (Fliers, et al., 2009).  These 
studies have examined functions such as control during movement, gross motor movements, 
fine motor movements and overall coordination (Fliers, Vermeulen et al. 2009).  Poor motor 
performance was noted in the ADHD group compared to the control group (Fliers, 
Vermeulen et al. 2009).  In addition, it has been shown that adults with ADHD often have 
linguistic and spatial deficits along with executive function deficits (Wolf 2001).  Therefore, 
it is possible that individuals with ADHD may have decreased balance.  This could be 
important to note when using balance as measure of concussion assessment.  
ADHD and Clinical Measures of Concussion  
While the effect of ADHD on cognitive function has been shown throughout the 
literature, there is limited research regarding the affect of ADHD on commonly used clinical 
concussion measures.  Normative data for clinical concussion measures exists, but the effect 
of ADHD on these scores is not taken into account. In the absence of a baseline evaluation, 
deciphering differences between pre-existing deficits and those that are a result of head 





related to lower baseline cognitive performances on a battery of neuropsychological 
concussion measures in a multi-university sample of college football players (Collins, 
Grindel et al. 1999).  Another study by Solomon et al. collected baseline data for NFL 
players and found that individuals with a diagnosed learning disability, some of which had 
ADHD, had decreased verbal and visual memory scores (Solomon and Haase 2008).  
Although these studies suggest a decreased performance in individuals with ADHD, further 
research must be conducted.  In addition, there is a lack of research examining the effect of 
stimulant medications on clinical measures of concussion.  
Rationale for Study 
There is little research examining ADHD in the collegiate population.  The few studies 
that have been conducted examining college students with ADHD are not without their 
limitations.  The studies have a lack of comprehensive clinical evaluations confirming the 
diagnosis of ADHD or have used measures that have not been deemed valid and reliable in 
the college aged population (DuPaul, Weyandt et al. 2009).   On the other hand, there have 
been numerous studies examining the validity and reliability of using multiple concussion 
assessment tools in conjunction to assess concussion.  Most of the commonly used tools have 
been deemed both valid and reliable.  
In order to be able to diagnose, evaluate and manage concussion properly, it is important 
to correctly interpret scores on clinical measures of concussion.  Limited research is available 
examining the effects of ADHD on clinical measures of concussion.  Understanding the 
relationship between ADHD and concussion evaluation is important because clinicians are 
faced with the challenging task of properly testing athletes prior to and following injury. 





concussion measures is also poorly understood. Therefore, the purpose of this study was to 
examine the effects of ADHD and stimulant medications used to treat ADHD on commonly 
used clinical measures of concussion, including CNS Vital Signs (CNSVS), the Balance 
Error Scoring System (BESS) and the Standardized Assessment of Concussion (SAC).  A 
secondary purpose was to examine the test-retest reliability of commonly used clinical 
concussion measures, including CNSVS, the BESS and the SAC in individuals with ADHD 
compared to matched controls.  
 




Participants in the study consisted of a convenience sample of thirty-four physically 
active college students. Seventeen participants (nine males and eight females) were in the 
ADHD group (age: 21.294 ± 2.02 years, previous number of concussions: 0.65 ± 0.70) and 
seventeen participants (nine males and eight females) were in the matched control group 
(age: 21.294 ± 2.05 years, previous number of concussions: 0.65 ± 0.70).  Participants in the 
control group were matched by gender, age and concussion history to participants in the 
ADHD group.  Participants included in the ADHD group had to meet the following criteria: 
1) declare that they have been diagnosed with ADHD, 2) complete the ADHD rating scale to 
confirm they meet the ADHD criteria (Appendix4), 3) provide proof of a prescription for 
stimulant medication. The ADHD rating scale, developed as part of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV), consists of a series of questions regarding 
inattentiveness and hyperactivity. This tool has been used as a diagnostic criterion for 
ADHD.  Although, not commonly used in isolation, it identifies three separate sub-types of 
ADHD including inattentive, hyperactive/impulsive and a combined type.  In order to 
participate each ADHD participant had to meet the criteria of one of the three sub-types 
(Appendix 4). All matched controls completed the ADHD rating scale and were not included 





All participants were physically active, defined as consistently participating in at least 
30 minutes of cardiovascular and/or resistive training at least 4 times per week for the past 
five months. Individuals reporting a history of three or more previous concussions, known 
vestibular dysfunction, or any lower extremity injury or concussion in the past six months 
were excluded from both groups. 
Procedures 
Participants reported to the University of North Carolina at Chapel Hill Matthew Gfeller 
Sport-Related Traumatic Brain Injury Research Center for testing.  All participants were 
administered the CNSVS, BESS and SAC on three separate occasions, between seven and 
nine days apart.  The means and standard deviations for time between testing session is 
presented in Table 3.1.  The testing order was counterbalanced between all participants at the 
first testing session (Table 3.2). Participants then repeated the same test order at all three 
sessions.  Prior to data collection, all participants filled out a questionnaire to ensure that all 
inclusion and exclusion criteria were met. All participants expressed their agreement to 
participate by signing and informed consent approved by the Institutional Review Board at 
the University of North Carolina at Chapel Hill.  
The control group was administered the CNSVS, BESS and SAC on three separate 
occasions, without any change in conditions.  For the participants in the ADHD group, the 
first two testing sessions were completed off medications, while the third testing session was 
completed on medication. For the non-medicated testing session, ADHD participants did not 
take their stimulant medication for at least 24 hours prior to the testing session. For the 
medicated testing session, participants in the ADHD group took their stimulant medication 





participant occurred exactly seven days apart and were held at approximately the same time 
of day (within two hours of prior testing sessions).  For morning testing sessions, testing was 
completed prior to the participant‘s first class.  For evening testing sessions, testing was 
completed at least four hours after the conclusion of the participant‘s last class and the 
participant had three hours or less of classes on the testing day. Every effort was made to 
avoid disrupting the normal medication schedule of participants with ADHD.  A 
questionnaire was also administered to all participants prior to each testing session, which 
included information regarding hours of sleep, hydration and eating habits (Appendix 5).    
Measurement and Instrumentation 
CNS Vital Signs (CNS Vital Signs, LLC, Chapel Hill, NC) consists of a series of 
computerized neurocognitive tests.  One of the purposes of CNSVS is to detect changes in 
neurocognitive performance over time, allowing for assistance in the evaluation of 
concussion.  Some advantages of CNSVS include millisecond timing, allowing for accurate 
detection of even small cognitive changes, immediate automated scoring, ease of exporting 
the scores and randomized presentation of data, allowing for long-term repeated 
administration of the test.  In addition, CNSVS allows for customized testing, meaning the 
test administrator can choose which tests to include in each evaluation. CNSVS subtests are 
described in Appendix 1. A multitude of cognitive domains are included and are known to be 
sensitive to most causes of mild cognitive dysfunction (Gualtieri, CT & Johnson, LG, 2006).  
Results include scores for the following clinical domains: neurocognitive index, composite 
memory, verbal memory, visual memory, processing speed, executive function, psychomotor 
speed, reaction time, complex attention and cognitive flexibility. Each participant was 





sustain their attention throughout the entire test.  CNSVS has been shown to be both valid 
and reliable (Gualtieri, CT & Johnson, LG, 2006).  All participants were administered the test 
in a quiet, controlled setting.  The test was administered to one to two athletes at a time, with 
at least one computer between participants.  Participants were given a set of instructions prior 
to test administration.  Participants were told to be sure to read all instructions and to sustain 
their full effort throughout the test.  They were also instructed that the goal for most of the 
tasks was to be respond as quickly as possible, while still being accurate.  In addition, they 
were told that some of the tasks have practice tests and some of the tasks are similar.  Finally, 
participants were instructed to notify the test administrator if they had any questions 
throughout the test.  These instructions were given prior to each test administration.  The test 
took approximately 30 minutes for each participant to complete. 
The BESS is an objective assessment tool developed to assess postural stability 
following concussion.  It is portable, cost-effective and can be used in the absence of a more 
expensive or sophisticated tool (Guskiewicz 2003; Hunt, Ferrara et al. 2009).  It is also one 
of the most commonly used concussion assessment tools amongst athletic trainers (Ferrara, 
McCrea et al. 2001).  The BESS involves three different stances (double leg, single leg and 
tandem stance), which are completed twice (once on a firm surface and once on an unstable 
surface), for a total of six twenty second trials (Guskiewicz 2003; Hunt, Ferrara et al. 2009). 
An Airex medium-density foam pad (20" L x 16.4" W x 2 1/2" H) (Power Systems Airex 
Balance Pad 81000, Knoxville, TN) was used for the unstable surface.  For balance in the 
double leg stance, participants were instructed to stand as tall as possible with hands on iliac 
crest and eyes closed, while maintaining balance with both feet touching.  For the single leg 





eyes closed, while maintaining balance on their non-dominant limb with their dominant limb 
in approximately twenty degrees of hip flexion and forty-five degrees of knee flexion. For 
balance in the tandem stance, participants were instructed to stand heel-to-toe with their non-
dominant limb in back, hands on their iliac crests and eyes closed. Leg dominance was 
defined as whichever leg the participant would use to kick a soccer ball for maximum 
distance.  If participants moved out of the test position at any point, they were reminded to 
return to a stable testing position as soon as possible and continue with the trial.  Each stance 
was demonstrated prior to data collection. The test took about five minutes to administer. All 
trials were videotaped and scored after testing to help ensure accuracy.  Errors included 
lifting hands off iliac crests, opening eyes, stepping, stumbling or falling, moving the hip into 
greater than thirty degrees of flexion or abduction, forefoot or heel losing contact with the 
ground or remaining out of the testing position for more than five seconds (Riemann and 
Guskiewicz 2000).  Errors were recorded for each 20-second trial by the primary 
investigator. Errors were summed for firm stance trails, foam stance trials, and total of all six 
trials.  The BESS has found to be both valid and reliable (Broglio, Macciocchi et al. 2007; 
Hunt, Ferrara et al. 2009). 
The SAC is a paper-and-pencil test that is used to evaluate mental status.  The SAC 
was designed in order to provide immediate information to athletic trainers and other medical 
providers regarding the management of head injuries.  It was created for the purpose of rapid 
sideline evaluation following a head injury sustained during a sporting event.  Along with the 
BESS, the SAC is also one of the most commonly used concussion assessment tools amongst 
athletic trainers (Ferrara, McCrea et al. 2001).  The SAC includes assessments of orientation, 





valid and reliable in college athletes (McCrea, Kelly et al. 1998; Valovich, Perrin et al. 2003; 
Bleiberg, Cernich et al. 2004). Participants were administered a different form of the SAC 
containing new words lists and digit recall content at each testing session to minimize a 
practice effect.  The SAC was administered in a quiet, controlled environment.  Each test 
took about five minutes to administer.   
Data Reduction 
 For data reduction, all recorded scores on the BESS and SAC were entered manually 
into SPSS.  Output scores from CNSVS were exported into an excel spreadsheet.  A single 
participant in the ADHD group presented with invalid CNSVS scores during the second 
session, due to having a Neurocognitive Index score of less than one hundred. The 
participant‘s second session CNSVS data were excluded from all analyses thereby excluding 
them from all CNSVS analyses.  It was quite evident that the participant did not put forth full 
effort on the second testing session perhaps due to being highly symptomatic, with a 
symptom score of 38.  
Data Analysis 
 All data were analyzed using SPSS Version 17.0 (SPSS Inc, Chicago, Illinois).  An a 
priori alpha level was set at 0.05.  We performed separate 2 (group) x 2 (session—2 and 3) 
mixed model repeated measures ANOVAs to address our first three research questions. Thus, 
these analyses allowed us to determine the effect of medication use on outcome measures 
within the ADHD group (on vs. off; research question 1), and to compare the differences in 
outcome measures between the control group and the ADHD group under both on (research 
question 2) and off (research question 3) medication conditions.  Tukey post hoc analyses 





addition, in order to examine the differences in practice effects between the control group 
and the ADHD group when off their medication (research question 4), separate 2 (group) x 2 
(session—1 and 2) mixed model repeated measures ANOVAs were utilized.  Tukey post hoc 
analyses were again employed when the omnibus test for interaction effects were significant.  
A summary of data sources and analyses is presented in Table 3.3. An executive summary is 






Table 3.1: Time between testing sessions  
 
Group Time between testing session 
1 and testing session 2 (days) 
Time between testing session 
1 and testing session 2 (days) 
ADHD (n=17) 7.12 ± 0.33 
 
7.47 ± 0.72 
Control (n=17) 7.24 ± 0.56 7.24 ± 0.44 
Both (n=34) 7.18 ± 0.46 
 








Table 3.2: Possible Counterbalance Order  
 
 
Testing Order Option First Test Second Test Third Test 
1 BESS CNSVS SAC 
2 BESS SAC CNSVS 
3 SAC BESS CNSVS 
4 SAC CNSVS BESS 
5 CNSVS BESS SAC 










Description Data Source Comparison Method 
1 Is there a significant 
difference in scores on 
clinical measures of 
concussion in 
individuals with 
ADHD while on 
medication and off 
medication? 
IV: Session & 
Group 
DV: Scores on  
CNSVS (10), 
BESS (1) and 
SAC (1) 
 
Clinical measure scores 
of session two (ADHD) 















Tukey post hoc  
when the 




2 Is there a significant 
difference in scores on 
clinical measures of 
concussion between 
individuals with 
ADHD while on 
medication and a 
matched control 
group? 
IV:  Session & 
Group 
DV: Scores on  
CNSVS (10), 
BESS (1) and 
SAC (1) 
Clinical measure scores 
of session three 
(ADHD) vs. session 
three (Control) 
 
3 Is there a significant 
difference in scores on 
clinical measures of 
concussion between 
individuals with 
ADHD while off 
medication and a 
matched control 
group? 
IV:  Session & 
Group 
DV: Scores on  
CNSVS (10), 
BESS (1) and 
SAC (1) 
Clinical measure scores 
of session two (ADHD) 
vs. session two 
(Control) 
 
4 Is there a significant 
difference in practice 
effect between 
individuals with 
ADHD off their 
medication compared 
to matched controls 




IV:  Session & 
Group 
DV: Scores on  
CNSVS (10), 
BESS (1) and 
SAC (1) 
Clinical measure scores 
of session one (ADHD 
and Control) vs. session 
two (ADHD and 
Control)  
 
Clinical measure scores 
of 
session two (ADHD 
and Control) vs. session 
three (ADHD and 
Control)  
Twelve 2 






Tukey post hoc  
when the 




      
CHAPTER IV 
RESULTS 
The primary purpose of this study was to examine the effects of stimulant medication 
on clinical concussion measures in physically active individuals diagnosed with ADHD. The 
secondary purpose was to examine the effects of ADHD in a physically active population on 
repeated sessions of a standard concussion assessment battery compared to a matched control 
group without ADHD.  Our study included an ADHD group with five participants classified 
as hyperactive/impulsive, five participants classified as inattentive and seven participants 
classified as combined type by the DSM-IV ADHD Rating Scale.  The ADHD and control 
group both had eight participants who had never sustained a concussion, seven participants 
who had sustained one concussion and two participants who had previously sustained two 
concussions. Demographic information for the participants is presented in Table 4.1.  
Descriptive and statistical results are presented in Table 4.2 (sessions two and three) and 4.3 
(sessions one and two).  A summary of results is presented in Table 4.4.   
Research Question One 
 Research question one examined the effects of stimulant medication in the ADHD 
group relative to matched controls on scores of concussion assessment tools comparing 






 We did not observe any significant group x session interactions or main effects for 
scores on composite memory, verbal memory, visual memory, executive function, complex 
attention or cognitive flexibility (Figures 4.2, 4.3, 4.4, 4.6, 4.9 and 4.10).  The absence of an 
interaction effect, combined with an absence of any main effects may mean that there was no 
added effect of stimulant medication for these CNSVS subtests.   However, we observed 
significant interaction effects for the neurocognitive index (F1,31=6.03, p=0.020), processing 
speed (F1,31=5.61, p=0.024), and psychomotor speed (F1,31=8.957, p=0.005) (Figures 4.1, 4.5, 
and 4.7).  Tukey post hoc analyses for all significant interactions revealed that the ADHD 
group performed better when on medication compared to sessions when they were off their 
medication (dcrit values: neurocognitive index=4.91; processing speed=5.18; and 
psychomotor speed=4.06). 
Balance Error Scoring System 
We did not observe any significant interaction effects for BESS total score.  
However, we did observe a significant session main effect (F1,32=5.17, p=0.030) (Figure 
4.11).  The ADHD and control group both performed better on the third testing session than 
they did on the second testing session.  Although the ADHD group performed better on their 
medication than off their medication, the control group improved between the second and 
third testing session as well.  This indicates that the increase in scores is likely due to a 
practice effect, as opposed to the medication.   
Standardized Assessment of Concussion 
 We did not observe any significant interaction effects for SAC total score.  However, 





ADHD and control group both performed better on the third testing session than they did on 
the second testing session.  Although the ADHD group performed better on their medication 
than off their medication, the control group improved between the second and third testing 
session as well.  This indicates that the increase in scores is likely due to a practice effect, as 
opposed to the medication. 
Research Question Two 
Research question two examined the differences in scores on concussion assessment 
tools between the ADHD group when they were on their medication (session three) 
compared to matched controls under their third test condition.  The same 2x2 repeated 
measures ANOVA models conducted for research question one were applied for this 
question. 
CNS Vital Signs 
As per above, we did not observe any significant group x session interactions or main 
effects for scores on composite memory, verbal memory, visual memory, executive 
function, complex attention or cognitive flexibility.  The absence of an interaction effect, 
combined with an absence of any main effects reflects that there was not a statistically 
significant difference between the two groups at session three on any of these subtests.  
While we observed significant interactions for the neurocognitive index, processing speed 
and psychomotor speed, post hoc analyses revealed no significant differences in scores 
between the ADHD and control group on the third testing session (Figures 4.1, 4.5 and 4.7).   
Balance Error Scoring System 
 We did not observe any significant interaction or group main effects for the BESS 





any group main effects means that there not a statistically significant difference between the 
two groups at session three for the BESS.   
Standardized Assessment of Concussion 
 We did not observe any significant interaction or group main effects for the SAC total 
score (Figure 4.12).  The absence of an interaction effect combined with the absence of any 
group main effects means that there is no statistically significant difference between the two 
groups at session three for the SAC.   
Research Question Three 
Research question three examined the differences in scores on concussion assessment 
tools between the ADHD group when they were off their medication (session two) compared 
to matched controls (session two). The same 2x2 repeated measures ANOVA models 
conducted for research questions one and two were applied for this question. 
CNS Vital Signs 
 As previously described, we did not observe any significant group x session 
interactions or main effects for scores on composite memory, verbal memory, visual 
memory, executive function, complex attention or cognitive flexibility (Figures 4.2, 4.3, 4.4, 
4.6, 4.9 and 4.10).  The absence of an interaction effect, combined with an absence of any 
main effects may mean that there was no difference in scores between groups for these 
CNSVS subtests.   However, we observed significant interaction effects for the 
neurocognitive index (F1,31=6.03, p=0.020), processing speed (F1,31=5.61, p=0.024), and 
psychomotor speed (F1,31=8.957, p=0.005) (Figures 4.1, 4.5, and 4.7).  Tukey post hoc 





the ADHD group on the second testing session (dcrit values: neurocognitive index=4.91; 
processing speed=5.18; and psychomotor speed=4.06). 
Balance Error Scoring System 
 We did not observe any significant interaction or group main effects for the BESS 
total score (Figure 4.11).  The absence of an interaction effect combined with the absence of 
any group main effects means that there is not a statistically significant difference between 
the two groups at session two for the BESS.   
Standardized Assessment of Concussion 
 We did not observe any significant interaction or group main effects for the SAC total 
score (Figure 4.12).  The absence of an interaction effect combined with the absence of any 
group main effects means that there is not a statistically significant difference between the 
two groups at session two for the SAC. 
Research Question Four 
Separate 2x2 repeated measures ANOVAs were also utilized to evaluate the 
differences in practice effect between individuals with ADHD compared to matched controls 
on commonly used clinical concussion measures, including the CNSVS, the BESS and the 
SAC between an initial taking of the tests (session one- ADHD: off medication) and a second 
taking of the tests (session two- ADHD: off medication).   
CNS Vital Signs 
 We did not observe any significant group x session interactions or main effects for 
scores on composite memory, verbal memory, visual memory, processing speed, 
psychomotor speed, or reaction time. We did observe a significant interaction effects on 





that the ADHD group performed better on their first testing session than they did on their 
second testing session (dcrit=6.37).  In addition, we observed a significant session main effect 
for scores on the neurocognitive index (F1,31=7.85, p=0.009), executive function 
(F1,31=17.30, p<0.005), complex attention(F1,31=5.46, p=0.026) and cognitive flexibility 
(F1,31=17.24, p<0.005) (Figures 4.13, 4.18 and 4.22).  In all cases, the scores of both the 
ADHD and control groups were higher on the second testing session, than on the first testing 
session, suggesting a significant practice effect existed for these subtests independent of 
group. 
Balance Error Scoring System 
We did not observe any significant group x session interactions or main effects for the 
BESS total score, suggesting there is no practice effect for either group 
Standardized Assessment of Concussion 
 We observed a significant group x session interaction effect for the SAC total score 
(F1,32=7.79, p=0.009)(Figure 4.24).  Tukey post hoc analyses revealed that the control group 
performed better on the first testing session than they did on the second testing session 
(dcrit=0.81), suggesting there is not a practice effect.  In addition, post hoc analyses revealed 
that the ADHD group performed statistically worse than the control group at both the first 
and second testing sessions, but closed the gap to some degree at the second session.  Thus, 
to no surprise the results revealed a main effect for group (F1,32=11.33, p=0.002), with the 






Power and Effect Size 
 There was a relatively low sample size for this study, with somewhat low effect sizes.  
The effect sizes for each of the CNS Vital Signs subtests, BESS total score and SAC total 
score are presented in Table 4.5.    
Summary of Results 
The effect of ADHD on cognitive function has been widely researched; however the 
effect of ADHD on concussion measures is not as well understood. The most important result 
from our study is that individuals with ADHD perform better on select neurocognitive 
measures when on their prescribed stimulant medication.  The ADHD subjects in our study 
presented with better processing speed, psychomotor speed and overall neurocognitive 
performance compared to when off medication (Research Question 1). The improved scores 
by the ADHD group in the absence of any improvement in the control group rules out the 
possibility that the improvement was due to a practice effect between session two and three.  
The stimulant medication appears to have had a positive effect on select cognitive domains 
and should be an important consideration for clinicians when administering cognitive tests. 
Despite these improvements, there were no differences between the ADHD and 
control group on neurocognitive, balance or mental status performance when the ADHD 
group was on their medication (Research Question 2).  However, the control group 
performed better than the un-medicated ADHD group on processing speed, psychomotor 
speed, and overall neurocognitive performance (Research Question 3).  The ADHD group 
performed better on their first testing session than their second testing session on composite 
memory, while there was no change in scores in the control group.  Conversely, the control 





in the ADHD group (Research Question 4).  Table 4.4 summarizes the statistically significant 
findings by highlighting the concussion measures in which ADHD subjects demonstrated a 














Testing Session 1 
(Mean±SD) 
Symptom Scores-
Testing Session 2 
(Mean±SD) 
Symptom Scores-
Testing Session 3 
(Mean±SD) 
ADHD 21.29±2.02 0.65±0.70 13.25±9.91 8.56±7.30 6.41±6.77 
Control 21.29±2.05 0.65±0.70 4.12±4.97 5.81±8.52 6.35±11.05 







Table 4.2: Descriptive and statistical results for CNSVS, BESS and SAC between 
sessions two and three  
 
 
**Significant group x session interaction effect 
* Significant main effect (group or session) 
 Group 
 






















p=0.462 Control 105.00 13.74 102.06 11.40 
Both 101.55  102.70  
Composite Memory 
Domain Score 







p=0.122 Control 107.88 17.12 97.47 16.49 
Both 101.33  96.39  
Verbal Memory Domain 
Score 





p=0.227 Control 105.41 18.19 97.53 18.80 
Both 99.64  94.70  
Visual Memory Domain 
Score 





p=0.234 Control 107.29 14.50 98.06 15.66 
Both 102.45  98.79  
Processing Speed 
Domain Score 








Control 110.65 17.34 109.88 15.44 
Both 107.00  110.39  
Executive Function 
Domain Score 






p=0.897 Control 107.65 14.20 107.65 14.20 
Both 104.12  103.64  
Psychomotor Speed 
Domain Score 







p=0.005* Control 107.82 17.00 107.88 16.91 
Both 104.61  108.79  
Reaction Time Domain 
Score 






p=0.128 Control 101.71 16.36 101.29 12.41 
Both 99.36  102.61  
Complex Attention 
Domain Score 






P=0.566 Control 100.94 17.14 99.00 17.15 
Both 99.58  100.94  
Cognitive Flexibility 
Domain Score 






P=0.301 Control 106.29 14.65 104.97 13.97 
Both 102.70  104.97  
BESS Total Score 





p=0.030* Control 9.53 2.67 9.06 2.08 
Both 10.12  9.18  
SAC Total Score 





p<0.005* Control 27.88 1.17 28.88 1.36 





Table 4.3 Descriptive and statistical results for CNSVS, BESS and SAC between 
sessions one and two  
 
 
**Significant group x session interaction effect  
 Group 






















Control 97.76 16.29 105.00 13.74 












Control 103.00 10.30 107.88 17.12 











Control 98.88 17.82 105.41 18.19 










Control 105.00 15.07 107.29 14.50 












Control 106.18 12.24 110.65 17.34 











Control 97.18 19.66 107.65 14.20 












Control 99.88 29.32 107.82 17.00 
Both 100.06  104.61  
Reaction Time 
Domain Score 







Control 92.35 18.48 101.71 16.36 











Control 91.29 37.01 100.94 17.14 











Control 96.00 20.72 106.29 14.65 
Both 92.48  102.70  
BESS Total 
Score 









Control 10.47 2.85 9.53 2.67 
Both     
SAC Total 
Score 















































2: ADHD on 
medication 
vs. controls 
     





 Control > 
ADHD 













  Control 




No significant results were observed for Verbal Memory, Visual Memory, Executive 
Function, Reaction Time, Complex Attention, Cognitive Flexibility, or BESS Total Score, 














Domain Effect Size (Cohen’s d) 
ADHD S3: ADHD S2 
Effect Size (Cohen’s d) 
Control S3:ADHD S3 
NCI 0.61 0.13 
Composite Memory 0.06 0.14 
Verbal Memory 1.12 0.33 
Visual Memory 0.03 0.11 
Processing Speed 0.79 0.08 
Executive Function 0.015 0.55 
Psychomotor Speed 0.92 0.13 
Reaction Time 0.30 0.20 
Complex Attention 0.34 0.04 
Cognitive Flexibility 0.56 0 
BESS Total Score 0.47 0.10 









*Significant interaction effect 
  ADHD Session 3 > ADHD Session 2 (Research Question 1) 










































































































































































































































*Significant interaction effect 
  ADHD Session 3 > ADHD Session 2 (Research Question 1) 












































































































*Significant interaction effect 
  ADHD Session 3 > ADHD Session 2 (Research Question 1) 

































































































































































































































*Significant session main effect (F1,32=16.00, p<0.005). 
 Control S3 > Control S2 
  ADHD S3> ADHD S2 

































































































*Significant interaction effect  





























































































































































































































































































































































































































































































*Significant interaction effect (F1,32=7.79, p=0.009) 
  Control session 1 > Control session 2 
  Control session 1 > ADHD session 1 
  Control session 2 > ADHD session 2 
      
CHAPTER V 
DISCUSSION 
The effect of ADHD on cognitive function has been widely researched; however, the 
effect of ADHD on concussion measures is not as well understood. The most important result 
from our study is that individuals with ADHD perform better on select neurocognitive measures 
when on their prescribed stimulant medication.   
Effects of Stimulant Medications 
We expected to see the medications have a positive effect on overall neurocognitive 
functioning by increasing arousal of the Central Nervous System (CNS).  The theory behind 
stimulant medications is that they increase arousal and alertness of the (CNS) through 
stimulation of norepinephrine and dopamine (Volkow, Gur et al. 1998; Vaughn, et al., 2011; 
Rowe, Robinson & Gordon, 2005).  One study found that stimulants suppress the locus 
coeruleus, which reduces stimulation of the thalamic reticular nucleus, ultimately improving 
cortical arousal (Rowe, Robinson & Gordon, 2005).  Therefore, it is not surprising that the 
ADHD group improved on overall neurocognitive functioning while medicated.  In fact, a study 
by Riordan et al, also found that a stimulant medication improved overall performance on a 
battery of neuropsychological tests including measures of motor speed, processing speed and 
distractibility in an adult ADHD group (Riordan, et al., 1999).  Furthermore, we expected to 
observe positive effects of medication on both the processing speed and psychomotor speed 




stimulant medications have been shown to improve concentration and attention (Hickey and 
Fricker 1999). 
We expected to observe a positive effect of medication on all measures of CNSVS, but did 
not observe an effect of medication on measures of composite memory, verbal memory, visual 
memory, reaction time, complex attention or cognitive flexibility.  In addition, we expected to 
see a positive effect of medication on the BESS and SAC.  A probable reason the medication did 
affect many factors of the CNSVS, BESS or SAC is because the ADHD group did not have 
deficits in these categories compared to a control group, when they were off their medication.  
Although previous studies have found stimulant medications to have an effect on some of 
domains of CNS Vital Signs, it has also been observed that as individuals with ADHD age and 
mature from the adolescent population to adulthood, their test scores normalize (Gualtieri and 
Johnson 2005).  Therefore, a collegiate population who is likely to be intelligent and motivated 
and have their ADHD treatment under control is more likely to have normal neurocognitive, 
balance and mental status scores compared to an adolescent or child population.   
Our study suggests that although stimulant medication did not appear to improve balance 
or mental status, it did affect some neuropsychological components, including overall 
neurocognitive performance, processing speed and psychomotor speed.  Based on the results of 
our study, ADHD athletes should complete both their baseline and post-injury tests on their 
prescribed stimulant medications.  The majority of stimulant medications are prescribed to be 
taken on a daily basis. This study observed that when the ADHD participants were on their 
medication, there were no differences between their scores and the control group‘s scores.  
However, when the ADHD group was off their medication, there were difference in 




In some cases, it may not be feasible for the individual to be on their medication for both 
the baseline and post injury testing.  For example, in some settings, it may be too difficult to 
notify all ADHD athletes who are prescribed a stimulant medication to make sure they take their 
medication prior to the testing session.  When this is the case, it could be helpful to document the 
medication status of the athlete stay constant across sessions.  Questions such as: ―Have you ever 
been diagnosed with attentional deficit hyperactivity disorder (ADHD), attentional deficit 
disorder (ADD) or any other learning disability?‖, ―If so, when were you diagnosed?‖, ―Do you 
currently take any type of medication for the treatment of ADHD, ADD or other learning 
disability?‖, ―When did you first start taking the medication you are currently taking?‖, ―What 
type of medication are you on and what is your dose?‖, ―How often do you take your 
medication?‖, ―Do you think your medication works?‖ and ―How long has it been since you last 
took your prescribed medication?‖, should be added to the standard battery of concussion 
assessment tools.   This will allow for a better interpretation of post-injury scores, because it will 
allow the clinician to know if the testing sessions were conducted under the same or similar 
medication statuses.  If testing sessions are held under different medication statuses, test scores 
should be carefully interpreted as medication status can affect some of the scores. 
Attention Deficit Hyperactivity Disorder (ADHD) 
 We observed differences in scores on the NCI, processing speed and psychomotor speed 
portions of CNS Vital Signs between the control group and the ADHD group, when the ADHD 
group was off their medication.  On all three domains, the control group performed better than 
the ADHD group.  There was no significant difference between the groups on measures of 
balance or mental status.  While we initially hypothesized that the control group would perform 




status, it is plausible that the ADHD group may not be impaired with certain types of memory, or 
balance.  Most studies that showed memory impairment within the ADHD population studied 
working memory (which involves retaining and manipulating information for several seconds), 
or recall memory, while CNS Vital Signs assesses recognition memory (Gropper and Tannock 
2009; Valera, Brown et al. 2009).  It is likely that recognition memory is easier for the ADHD 
population and therefore they are able to perform similarly to a control group on the verbal and 
visual memory measures. 
However, it is interesting that there were no significant differences between the groups on 
measures of reaction time, complex attention and cognitive flexibility, because they have been 
found to be influenced by ADHD (Gualtieri and Johnson 2005).  It is possible that changes were 
not seen in this group, because individuals with ADHD who are able to perform academically at 
the collegiate level may have a milder form of the disorder (Wilmshurst and Peele).  In addition, 
it is possible that compared to the adolescent population, where the cognitive and balance 
deficits are typically seen, the collegiate population likely tends to be more mature and is more 
likely to have found the best treatment for their disorder.  It has been observed that individuals 
with ADHD experience a decrease in both the frequency and severity of symptoms as they age 
(Hart, et al. 1995).  Since differences between the adolescent and adult ADHD population has 
been shown, it has even been suggested that age-specific assessments of ADHD should be 
considered (Ramtekkar, Reiersen et al.).  Furthermore, a study by Schwartz et al. found that there 
was no difference between scores on Stroop interference tasks between an ADHD and age 
matched controls, and in our study the scores from the Stroop interference tasks make up part of 
the scores for reaction time, complex attention and cognitive flexibility scores (Schwartz, 




Our study indicates that when ADHD individuals are on their stimulant medication, their 
scores are comparable to those of matched controls.  This provides an important implication for 
serial testing of ADHD athletes.  If individuals with ADHD are comparable to matched controls, 
when they are on their stimulant medications, then it is desirable that individuals with ADHD to 
take their stimulant medication prior to baseline and post-injury testing.  In the case where an 
athlete with ADHD sustains a concussion, but does not have a baseline measure, the team 
physician and athletic trainer should instruct the athlete to take their stimulant medication prior 
to follow-up testing to allow for comparisons with normative data.  
Recent recommendations suggest that baseline testing on neurocognitive, postural 
control, and symptomatology measures be completed prior to sport exposure for all athletes, so 
that appropriate comparisons can be made post-injury. Our study suggests that both ADHD and 
stimulant medications affect scores on concussion assessment tools. Clinicians should make an 
effort to identify athletes with ADHD prior to concussion baseline evaluation and treat these 
athletes with special care to ensure quality baseline scores.  
Practice Effects 
A secondary aim of our study was to examine differences in practice effects between the 
control group and the ADHD group when they were off their medication.  We observed that the 
ADHD group performed better on the composite memory portion of CNSVS on their first testing 
session than their second testing session, while there was no significant difference between 
testing sessions in the control group.  Additionally, the control group performed better on the 
first testing session than on the second testing session for the SAC total score, while there was no 
significant difference between testing sessions in the ADHD group.  CNSVS has been shown to 




test-retest reliability between the ADHD and control population.  We hypothesized that the 
control group may benefit from a practice effect between the first and second testing session, 
while the ADHD group might not.  Our study suggests that the ADHD group declined in 
performance between the first and second testing session on the composite memory portion of 
CNSVS.  This could be due to the fact that the ADHD group performed better on the first testing 
session, due to the novelty effect, or the excitement associated with completing a task for the first 
time, while the task was not new during the second testing session and they knew that they 
would have to sustain their attention for a long period of time (Poppenk, Walia et al. 2008).  
Composite memory was likely affected because the score is a combination of scores on both 
verbal and visual memory, in which tasks are repeated the end of the testing battery.  Therefore, 
they require attention over an extended period of time.   
Another interesting finding is that the control group had decreased scores between their 
first and second testing session on the SAC.  Although this finding was statistically significant, it 
is not clinically significant (difference of 1.00 point between testing sessions).  McCrea et al. 
demonstrated that in a high school and collegiate sample of football players, the average change 
in scores from baseline to post injury was 3.50 (McCrea, Kelly et al. 1998).  In addition, studies 
in the high school population have found that there is generally no practice effect associated with 
the SAC (Valovich, Perrin et al. 2003).    
Although not part of the primary research questions, we did observe significant main 
effect of session on neurocognitive index, executive function, complex attention and cognitive 
flexibility scores on CNSVS, with both groups scoring higher on the second testing session, than 
on the first testing session.  This suggests that there may be a practice effect in both the control 




cognitive flexibility portions of CNSVS when the test is re-administered with 7-9 days of initial 
administration.  These results differ from the previous findings of Gualtieri et al; however, our 
study utilized a shorter time period between testing sessions (Gualtieri and Johnson 2006). 
It is important to continue examining differences in practice effects between the ADHD 
population both on and off medication and control group as these comparisons have important 
clinical implications.  When interpreting post-injury scores, reliable change indices and practice 
effects should be taken into account.  However, it is important to note that these reliable change 
indices and practice effects may be different in the ADHD population.  In addition, they could 
differ within the ADHD population, depending whether or not they are on or off medication.  
Practice effects within the ADHD population needs to be examined in future studies. 
Limitations 
 We acknowledge there are some limitations with the procedures of this study.  This study 
only examined individuals with ADHD who were prescribed an immediate release stimulant 
medication for the treatment of ADHD.   Athlete‘s taking non-stimulant medications may 
respond differently than our sample of ADHD athletes.  Both the type and dose of medication 
could influence the effects of medication.  Also, the time since ADHD diagnosis, amount of time 
taking current prescribed stimulant medication and ADHD subtype could influence the scores on 
concussion assessment tools and the effects of the medication on scores. We attempted to control 
for these variables, by making sure that all ADHD participants had been previously diagnosed 
with ADHD and had taken their current stimulant medication for at least 6 months prior to their 
first testing session. Heterogeneity among the ADHD group may have limited our ability to 
identify significant differences across testing sessions. The ADHD group consisted of a 




individuals with different subtypes, although similar in many ways, experience different forms of 
the disorder. It seems possible, and likely, that ADHD individuals with different subtypes will 
present with different neurocognitive and postural control capabilities. Also, ADHD participants 
were diagnosed by different physicians prior to enrolling in our study. Discrepancies in ADHD 
diagnosis among diagnostic criteria could contribute to the heterogeneity of this group. 
Furthermore, the control group was not administered the ADHD rating scale to rule out the 
possibility of a missed ADHD diagnosis within the control group.  Another limitation is that 
diagnosis of ADHD and the number of previous concussions were self reported.  However, 
ADHD participants did meet the criteria for diagnosis on the DSM-IV criteria and did present a 
prescription for a stimulant medication.  Additionally, the effect of stimulant medications in the 
ADHD group could have been mildly washed out by the practice effect between the second and 
third testing session.   Finally, this study could have benefitted from a larger sample size. We 
observed several low effect sizes for some dependent variables. This may have limited our 
ability to detect interaction effects between groups and sessions.  
Future Research 
 In the current study we only analyzed ADHD and control differences in postural control, 
neurocognition, and mental status in healthy physically active individuals. Graded symptom 
assessments are another integral piece to clinical concussion management. As part of our 
secondary analysis, we observed a significant interaction effect on the symptom scores 
(F(2,60)=40.310, p<0.005).  The ADHD group had a significantly higher score on the first testing 
session than the control group.  It is interesting that the ADHD group had significantly higher 
scores on the first testing session, but not the second testing session, considering they were off 




medications, which caused them to experience symptoms for the first testing session.  However, 
for the second testing session, they prepared themselves to be symptomatic and therefore, they 
did not report as severe symptoms.  The relationship between symptoms and scores on clinical 
measures of concussion, especially in the athletic ADHD population requires further research.   
 There are several other factors that could affect the scores of ADHD individuals on 
concussion assessment tools.  Therefore, future research should examine the influence of gender, 
type of medication and dose of medication on the effects of concussion assessment tools.  
Several studies suggest that gender, type and dose of medication could play a role in the efficacy 
of stimulant medications used for the treatment of ADHD.  For example, a study by Swanson et 
al found that the optimal dose for cognitive effects was lower than that for behavioral effects, 
suggesting that different doses of medication could provide different benefits (Swanson 2011).   
A future study could examine differences between two groups of ADHD individuals, one with a 
higher dose of medication and the other group with a lower dose of medication.  It is possible 
that the different groups would improve on different areas of the tests when they are on their 
medication.  In addition, future studies could examine the effect of ADHD subtype on scores of 
concussion assessment tools.   
Conclusions and Clinical Implications 
 Our findings are consistent with current findings that stimulant medications used to treat 
ADHD have been shown to have an effect on portions of cognitive function, including overall 
neurocognitive functioning, processing speed and psychomotor speed (Agay, N., Yechiam, E., 
Carmel, Z., & Levkovitz, 2010; Brams, M., Moon, E., Pucci, M., & Lopez, F. A., 2010; 
Cornforth, C., Sonuga-Barke, E., & Coghill, D., 2010).  Since stimulant medications have been 




patients‘ baseline testing and post injury testing occurs under the same or similar medication 
statuses.  ADHD athletes perform similar to controls when under the influence of stimulant 
medication. Sports medicine professionals should ensure that ADHD athletes complete 
concussion evaluation while on stimulant medication if comparing to normative data is 
necessary. There may be differences in practice effects between individuals with ADHD and the 
average population.  This study found differences in practice effects on the composite memory 
and SAC total score. Our study suggests that it is especially important to obtain a baseline 
measure in individuals with ADHD, because it is difficult to compare scores to normative data. 
At the minimum, clinicians should note individuals with ADHD medication statuses upon 






The CNS Vital Signs
TM
 Test Battery 
 
Verbal Memory Test (VBM) & Visual Memory Test (VIM) 
Vital Signs includes parallel tests of verbal memory (word list learning) and visual memory (figure 
learning).  The tests are virtually identical, but one uses words as target stimuli, the other, geometric 
shapes.  The verbal memory test (VBM) is an adaptation of the Rey Auditory Verbal Learning Test. In the 
CNS Vital Signs version, fifteen words are presented, one by one, on the screen.  A new word is 
presented every two seconds.  The subject is asked to remember these words.  Then a list of thirty words 
is presented.  The fifteen target words are mixed randomly among fifteen new words.  When the subject 
recognizes a word from the original list, he or she presses the space bar.  After this trial of thirty stimuli, 
the subject goes on to do the next six tests.  At the end of the battery, about 20 minutes later, the fifteen 
target words appear again, mixed with 15 new non-target words. The Visual Memory Test (VIM) in CNS 
Vital Signs is based on the Rey Visual Design Learning Test; the latter is, in turn, a parallel to the Rey 
Auditory Verbal Learning Test, using geometric figures rather than words, and requiring the subject to 
draw the figures from memory.  In CNS Vital Signs, the visual memory test is just like the verbal memory 
test.  Fifteen geometric figures are presented; the subject has to identify those figures nested among 
fifteen new figures.  Then, after five more tests, there is a delayed recognition trial. The VBM draws from 
a ―reservoir‖ of 100 plus words selected from word-frequency tables.  The VIM draws from a reservoir of 
60 simple geometric designs.  The scoring is straightforward: correct hits and correct passes, immediate 
and delayed.  Correct responses from VBM and VIM are summed to generate a composite memory or 
memory domain score.  The highest score one can attain is 120; the lowest is 60.  Scores below 60 
suggest willful exaggeration.  
Finger Tapping Test (FTT) 
The FTT is one of the most commonly used tests in neuropsychology, because of its simplicity and 
reliability, and because it generates relevant data about fine motor control, which is based on motor 
speedas well as kinesthetic and visual-motor ability.  The FTT is believed to be one of the most sensitive 
neuropsychological tests for determining brain impairment. In CNS Vital Signs, the FTT is a very simple 
test.  Subjects are asked to press the Space Bar with their right index finger as many times as they can in 
10 seconds.  They do this once for practice, and then there are three test trials.  The test is repeated with 
the left hand.  The score is the average number of taps, right and left. 
Symbol-Digit Coding (SDC) 
Coding has been a component of the Wechsler Intelligence Scales since 1944 (Digit Symbol Substitution, 
DSST).  The Symbol Digit Modalities Test (SDMT) is a variant of the Wechsler DSST, but the position 
of symbols and digits is reversed.  The clinical and psychometric properties of the SDMT are similar to 
those of the DSST.  Although the SDMT may be a ―harder‖ test, and thus more sensitive to neurotoxicity, 
performance on the SDMT and the DSST are highly correlated.  The SDC in CNS Vital Signs draws from 
a reservoir of 32 symbols.  Each time the test is administered, the program randomly chooses eight new 
symbols to match to the eight digits.  Scoring is the number of correct responses generated in 2 minutes. 
The total of right and left taps from the FTT and total correct responses on the SDC generates a composite 




The Stroop Test 
In 1935, the psychologist JR Stroop demonstrated that naming is slowed when subjects are asked to name 
the ink color of an incongruous color word; for example, the word ―blue‖ printed in red ink.  The 
incongruity of word color and word meaning generates an ―interference‖ effect. The Stroop test is still 
used as part of standard neuropsychological batteries and several computerized versions of the test have 
been developed.   It is a favorite test in studies of the neurocognitive effects of CNS drugs, especially 
anti-epileptic drugs. There have been several versions of the Stroop test over the years.  The modification 
adopted for CNS Vital Signs uses only four colors/color words (red, green, yellow, blue), and only one 
key is in play, the space bar.  The test has three parts.  In the first, the words RED, YELLOW, BLUE and 
GREEN (printed in black) appear at random on the screen, and the subject presses the space bar as soon 
as he or she sees the word.  This generates a simple reaction time score.  In the second part, the words 
RED, YELLOW, BLUE and GREEN appear on the screen, printed in color.  The subject is asked to press 
the space bar when the color of the word matches what the word says.  This generates a complex reaction 
time score.  In the third part, the words RED, YELLOW, BLUE and GREEN appear on the screen, 
printed in color.  The subject is asked to press the space bar when the color of the word does not match 
what the word says.  This part also generates a complex reaction time score, called the ―Stroop reaction 
time.‖  The Stroop reaction time is, on average 120 msecs longer than the complex reaction time 
generated in part two of the test (range, 78-188 msecs).  Part three also generates an error score. A domain 
score for ―reaction time,‖ or, to be more precise, information processing speed, is generated by averaging 
the two complex reaction time scores from the Stroop test. 
The Shifting Attention Test 
The Shifting Attention Test (SAT) measures the subject‘s ability to shift from one instruction set to 
another quickly and accurately.  In the SAT test, subjects are instructed to match geometric objects either 
by shape or by color.  Three figures appear on the screen, one on top and two on the bottom.  The top 
figure is either a square or a circle.  The bottom figures are a square and a circle.  The figures are either 
red or blue; the colors are mixed randomly.  The subject is asked to match one of the bottom figures to the 
top figure.  The rules change at random.  For one presentation, the rule is to match the figures by shape, 
for another, by color.  This goes on for 90 seconds.  The goal is to make as many correct matches as one 
can in the time allotted.  The scores generated by the SAT are: number correct, errors, and response time 
in milliseconds.  There is not a precise parallel to the SAT in the compendium of conventional 
neuropsychological tests, although Trails B and the Wisconsin Cart Sort are considered to be tests of 
shifting attention.  Computerized tests, however, like the NES2, CogState and CANTAB have shifting 
attention tests that are not dissimilar to the SAT .A domain score for cognitive flexibility is generated by 
taking the number of correct responses on the SAT and subtracting the number of errors on the SAT and 
the Stroop test. 
The Continuous Performance Test 
The CPT is a measure of vigilance or sustained attention or attention over time. It has been a popular 
test because of its robust relationship to psychiatric disorders. It is sensitive to CNS dysfunction in 
general, and is not specific to any particular condition. The CPT is also sensitive, for better or worse, to 
the effects of various drugs. The CPT in Vital Signs is a conventional version of the test, although it is 




stimulus ―B‖ but not to any other letter.  In five minutes, the test presents 200 letters.  Forty of the stimuli 
are targets (the letter ―B‖), 160 are non-targets (other letters).   The stimuli are presented at random, 
although the target stimulus is ―blocked‖ so it appears eight times during each minute of the test.  Scoring 
is correct responses, commission errors (impulsive responding), and omission errors (inattention).  The 
CPT also reports subjects‘ choice reaction time for each variable.  A domain score for ―complex 
attention‖ is generated by adding the number of errors committed in the CPT, the SAT and the Stroop. 
 
Non-verbal Reasoning Test (NVRT) 
The Reasoning test is usually less than 5 minutes as those who are capable can respond much more 
quickly than the time-out allows.  There are 15 presentations with 14 second response time. 
The test runs continuously for about 5 minutes.  It consists of a series of puzzles, or visual analogies, 
similar to those in Raven‘s Progressive Matrices.  The puzzles are progressively more difficult.  The 
subject identifies the correct response from a field possible answers by selecting a number to match the 




















































































ADHD RATING SCALE 
 
Adapted from the Diagnostic and Statistical Manual of Mental Disorders-IV Diagnostic Criteria 
Please answer the following questions by checking the appropriate box.  The questions are pertaining to your behavior over the past six 
months. 
When off your medication… Always/ 
Very Often 
Often Somewhat Rarely/ 
Never 
do you fail to give close attention to details or makes 
careless mistakes in schoolwork/homework? 
    
do you have difficulty keeping attention on tasks or play 
activities? 
 
    
do you think that you do not seem to listen when spoken to 
directly? 
 
    
do you feel like you do not follow through on instructions 
and fail to finish schoolwork or chore? 
 
    
do you have difficulty organizing tasks and activities? 
 
    
do you avoid or strongly dislike tasks that require sustained 
mental effort (e.g., homework)? 
    
do you lose things necessary for tasks or activities (e.g., 
pencils,books, etc)? 
 
    
are you easily distracted by outside stimuli? 
 
    
are you forgetful in daily activities? 
 
    
 
 
When off your medication… Always/ 
Very Often 
Often Somewhat Rarely/ 
Never 
do you fidget with hands or feet or squirm in your seat? 
 
    
do you leave your seat in situations in which remaining 
seated is expected (e.g., dinner table)? 
 
    
do you run about in situations where it is inappropriate? 
 
    
do you have difficulty performing tasks quietly? 
 
    
do you feel like you’re “on the go” or driven by a motor? 
 
    
do you talk excessively? 
 
    
do you blurt out the answers to questions before the 
questions have been completed? 
 
    
do you have difficulty awaiting your turn? 
 
    
do you interrupt or intrude on others? 
 
    
 




ADHD Rating Scale Grading: 
 
Inattentive sub-type: 
To meet the criteria for ADHD inattentive sub-type, there must be six or more boxes checked in the 
“Always or very often‖ and the ―Often‖ columns, for the first nine questions.  In other words, the child 
must have at least six of these symptoms which have persisted for at least 6 months to a degree that is 
maladaptive (significant impairment in social, academic, or occupational functioning) and inconsistent 
with developmental level  
 
Hyperactive/impulsive sub-type: 
To meet the criteria for ADHD hyperactive/impulsive sub-type, six or more of the symptoms should be in 
the ―Always 
or very often‖ and the ―Often‖ categories for the last nine questions. 
 
Combined sub-type: 
To meet the criteria for ADHD combined sub-type, both the inattentive and hyperactive/impulsive criteria 
must be met.  This means that six or more ―Always or very often‖ or ―Often‖ boxes were checked in both 











Please answer all of the questions in Part A / Part A and Part B   to the best of your ability.  If 
you have any questions, please ask your research assistant. 
 
Part A 
Gender: Male Female 
What is your date of birth?   ______/_____/_______ 
   (month) / (date) / (year) 
What year are you? Please check the correct response. 
Freshman    Sophomore   Junior    Senior Fifth Year   Graduate student  
How many days a week do you typically workout (cardio or resistive exercises)? 
____________days/week  
How long do you typically workout for on those days? _______________ minutes/day 
How long have you been working out? _____________ months or __________ years 
Have you suffered a head injury, vestibular dysfunction or any injury that has affected your physical 
activity within the past 6 months?  Please circle the correct response. Yes No 
If yes, please 
explain._____________________________________________________________________ 
Have you ever been diagnosed with a concussion? Yes No 
If so, how many? ___________ 
 
Have you ever been diagnosed with Attention Deficit Hyperactive Disorder?    Yes   No 








Have you been diagnosed with attention deficit hyperactivity disorder (ADHD)?  Yes No 
Approximately when were you diagnosed with ADHD? _______/_______ 
       (month) / (year) 
 
Are you currently taking medication for ADHD? Please circle the correct response. Yes   No 
Is your prescription a stimulant?  Yes No 
When did you start taking the medication you are currently using?  _______/______/_______ 
         (month) / (date) / (year) 
 
What days/times of the week do you typically take your medication?  If any conditions cause you to take 









Please answer all of the questions in Part A / Part A and Part B to the best of your ability.  If you 




How many hours did you sleep last night (please round to the nearest 15 minutes)?  _____hours 
&________ minutes 
How many classes have you had so far today?   _________ 
How much time have you spent in class so far today?  ____________ hours &___________ 
minutes 
How long has it been since the end of your last class? ____________ hours &___________ minutes 
Are you currently taking any medications, other than for the treatment of ADHD?  Yes    
 No 




Please list anything that you have had to eat today below: 
Please list anything you have had to drink today and approximately how much (fluid ounces), you have 
had of each fluid: 
Part B  
How long has it been since you last took a stimulant medication (please round to the closest 15 minutes)?   
_____hours &________ minutes 
If you take more than one type of stimulant medication, how long has it been since you took your other 
medication? 
_____hours&________ minutes   Or Circle: ___N/A_____ 
If you are on more than one type of stimulant medication, which one have you taken most recently? 









1. How do individuals diagnosed with ADHD perform on clinical measures of concussion when on 
stimulant medication compared to off stimulant medication? 
2. How do individuals diagnosed with ADHD perform on clinical measures of concussion when on 
stimulant medication compared to matched controls? 
3. How do individuals diagnosed with ADHD perform on commonly used clinical measures of 
concussion when off stimulant medication compared to matched controls? 
4. How do individuals diagnosed with ADHD perform on clinical measures of concussion across 
multiple testing sessions compared to matched controls? 
 
Independent Variables: 
1. Group: Individuals diagnosed with ADHD, matched controls 
2. Session: Testing session one, testing session two and testing session three 
a. ADHD Group Conditions Within Testing Sessions: 
i. off medication (testing session one and two) 
ii. on medication (testing session three) 
 
Dependent Variables: 
1. Scores on clinical measures of concussion 
a. CNS Vital Signs (CNSVS) 
i. 10 dependent variables: neurocognition index, composite memory domain score, 
verbal memory domain score, visual memory domain score, processing speed 
domain score, executive function domain score, psychomotor speed domain 
score, reaction time domain score, complex attention domain score, cognitive 
flexibility domain score 
b. Balance Error Scoring System (BESS) 
i. 1 dependent variables: total error score 
c. Standardized Assessment of Concussion (SAC) 
i. 1 dependent variables: SAC total score 
  
Participants: 
Participants in the study will consist of a convenience sample of 34 students from the University 
of North Carolina at Chapel Hill, who are physically active and between 18 and 24 years old.  Eighteen of 
the participants will have been diagnosed with ADHD and 18 participants will be matched controls. 
Participants in the ADHD group will be identified through recruitment efforts, and must meet three 
criteria: 1) declare that they have been diagnosed with ADHD, 2) complete the ADHD rating scale to 
confirm they meet the ADHD criteria, 3) provide proof of a prescription for stimulant medication. The 18 
control participants will be matched to ADHD participants based on gender, years of education 
completed, and concussion history.  
 
Inclusion Criteria: All participants must be between eighteen and twenty-four years old and must be 
physically active (defined as consistently participating in at least 30 minutes of cardiovascular and/or 
resistive training at least 4 times per week for the past 5 months).   
Exclusion Criteria: Sustained three or more concussions, known vestibular dysfunction, or any lower 






Participants were recruited using a convenience sample of physically active students at UNC-CH. 
Both groups were administered theCNSVS, BESS and SAC on three separate occasions. The control 
group will complete these measures without any change in conditions.  For the participants in the ADHD 
group, the first two testing sessions were completed ―off‖ medication, while testing session three was 
completed ―on‖ medication. For the ―off‖ medication testing sessions, ADHD participants did not take 
their stimulant medication for at least 24 hours before the testing session. For the ―on‖ medication testing 
session, participants in the ADHD group took their stimulant medication within one to three hours prior to 
the testing session.  All three testing sessions for each participant occurred between seven and nine days 
apart and were held at approximately the same time of day (within two hours of prior testing sessions).  
For morning testing sessions, testing must be completed prior to the participant‘s first class.  For evening 
testing sessions, testing was completed at least two hours after the conclusion of the participant‘s last 
class and the participant attended less than three hours of classes on the testing day. Efforts were made to 
avoid disrupting the normal medication schedule of participants with ADHD.  
Prior to their first testing session, each participant filled out a questionnaire to ensure that all 
inclusion and exclusion criteria were met.  In addition, the questionnaire includes information pertaining 
to the timing of stimulant medications.  Testing sessions were scheduled around the convenience of the 
participants.  Classes, sporting events and other activities requiring the use of stimulant medication will 
be taken into account when scheduling the testing sessions.   
 



















 The effects of medication on scores of the ADHD group, relative to the control group, 
and differences in scores between the control group and the ADHD group while both on and off 
medication, were examined using separate 2 (group) x 2 (session) mixed model repeated 
measures ANOVAs.  Tukey post-hoc was analyses were employed when the omnibus test for 
interaction effects were significant.  In addition, in order to examine the differences in practice 
effects between the control group and the ADHD group when off their medication, separate 2 
(group) x 2 (session) mixed model repeated measures ANOVAs were utilized.  Tukey post-hoc 
was analyses were employed when the omnibus test for interaction effects were significant. 
 
 
Interaction of interest: 
RQ1: Time session two (ADHD) vs. Time session three (ADHD) 
RQ2: Time session three (ADHD) vs. Time session three (Control) 
RQ3: Time session two (ADHD) vs. Time session two (Control) 
RQ4: Time session one (ADHD and Control) vs. Time session two (ADHD and Control)  











The effects of attention deficit hyperactivity disorder (ADHD) and stimulant medications 
on concussion assessment tools 
Context: Athletes with ADHD are at an increased risk for sustaining a head injury; however, the 
effects of ADHD and stimulant medications on concussion assessment tools are unclear.  
Objective: To examine the effects of ADHD and stimulant medications on concussion 
assessment tools.  Design: Repeated measures design. Setting: Controlled laboratory setting. 
Patients or Other Participants: Thirty-four physically active participants (17 diagnosed with 
ADHD, and 17 matched controls).   Interventions: All participants were administered CNS 
Vital Signs (CNSVS), Balance Error Scoring System (BESS) and Standardized Assessment of 
Concussion (SAC) on three separate occasions, each seven to nine days apart.  The ADHD group 
completed testing session one and two on medication and testing session three off medication.  
Main Outcome Measures: Score on concussion assessment tools: CNSVS (standard scores for 
core domains), BESS (firm, foam and total error score), and SAC (orientation, immediate 
memory, concentration, delayed recall and total score). Results: We observed a significant 
interaction effect for the neurocognitive index (F1,31=6.03, p=0.020),  processing speed 
(F1,31=5.61, p=0.024)  and psychomotor speed (F1,31=8.957, p=0.005), with Tukey post hoc 
analyses revealing that on all occasions,  the ADHD group performed better on medication than 
off medication and the control group performing better than the ADHD group on testing session 
two (off medication).  We observed a significant interaction effect on composite memory 
(F1,31=11.40, p=0.002) , with Tukey post hoc analyses revealing that the ADHD group performed 




significant group x session interaction effect for the SAC total score (F1,32=7.79, p=0.009), with  
Tukey post hoc analyses revealing that the control group performed better on the first testing 
session than they did on the second testing session 
Conclusions: Our study suggests that it is especially important to obtain a baseline measure in 
individuals with ADHD, because it is difficult to compare scores to normative data.  Also, we 
found that stimulant medication have a positive impact on some scores.  Therefore, baseline 
testing and post injury testing should occur under the same or similar medication statuses, or at 
minimum, individuals with ADHD‘s medication statuses should be noted prior to administration 
of concussion assessment tools.  Key Words: traumatic brain injury, attention deficit 





Concussion is a common neurological injury in sports, with an estimated 1.8 to 3.6 
million cases occurring each year (Langlois, Rutland-Brown et al. 2006). This may even be 
an underestimate as many concussions go unreported (McCrea 2004).  Concussion is a 
complex pathophysiological process within the brain resulting from traumatic biomechanical 
forces, such as a direct blow to the head, neck, face or elsewhere on the body, in which the 
forces are transmitted to the head (McCrory, Meeuwisse et al. 2009).  The evaluation of 
concussion involves a multi-faceted approach including: a thorough clinical evaluation, 
assessment of the patient‘s signs and symptoms, measures of postural-stability, and cognitive 
or neuropsychological testing (Guskiewicz, Bruce et al. 2004; McCrory, Meeuwisse et al. 
2009).  Current standards recommend testing athletes on these measures prior to athletic 
participation, in order to serve as a baseline for comparison, in the event that the athlete 
sustains a concussion (Guskiewicz, Bruce et al. 2004; McCrory, Meeuwisse et al. 2009).  
One reason behind the use of baseline testing is to provide a unique measure of an 
individual‘s performance in the absence of injury to control for ―extraneous variables‖, such 
as attentional or other disorders that may influence the testing measures (Guskiewicz, Bruce 
et al. 2004).  An example of an attention disorder is attention deficit hyperactivity disorder 
(ADHD), which is a behavioral syndrome primarily characterized by hyperactivity, 
impulsivity and inattention (National Institute for Health and Clinical Excellence Guidelines, 
2006). Attention Deficit Hyperactivity Disorder is commonly diagnosed in children, but it 
often persists into adulthood (Wolf 2001).  In fact, it is becoming more and more common 




176,000 to 528,000 currently enrolled in universities (Wolf 2001; Shifrin, Proctor et al. 
2009).   
Some studies report a higher rate of injuries in individuals with ADHD, speculating 
that individuals with ADHD are more likely to be inattentive and impulsive and less likely to 
foresee possibly negative consequences of their behaviors (Merrill, Lyon et al. 2009). A 
study by Merrill et al. showed that individuals with ADHD are more susceptible to head 
injuries.  Since this population may be more likely to sustain a head injury, it is essential that 
individuals with ADHD are properly evaluated and treated.  One way to ensure this is to 
make sure athletes with ADHD are administered the recommended baseline testing on 
various clinical measures of concussion.  In addition,  stimulant medications have been 
shown to be an effective treatment for ADHD and are commonly prescribed for that purpose. 
However, the use of stimulant medication on scores of clinical concussion measures is also 
poorly understood (Harpin 2008). It is possible that while on stimulant medications 
individuals with ADHD perform better than when off medication on clinical measures of 
concussion, but no previous studies have assessed this relationship.  
Clinical outcome measures provide clinicians with valuable information to utilize 
during evaluation and management of concussion and offer quantitative values for use in 
making return to play decisions.  Individuals with ADHD are prone to head injuries; 
however, the effect of ADHD on scores of commonly used concussion assessment tools is 
unclear.  In addition, the effects of the use of stimulant medication on these measures are also 
unknown.  Therefore, the purpose of this study was to examine the effects of ADHD and 
stimulant medications on commonly used clinical concussion measures, including the CNS 




Assessment of Concussion (SAC) in physically active individuals.  A secondary purpose was 
to examine differences in practice effect between individuals with ADHD compared to 
matched controls on commonly used clinical concussion measures, including the CNSVS, 
the BESS and the SAC.     
METHODS 
 We used a repeated measures design to compare an ADHD group to matched controls 
and to compare scores across all three testing sessions, with the ADHD group performing the 
first and second testing sessions off medication and the third testing session on medication.  
The independent variables were group (ADHD group, matched control group) and time 
(testing session one, testing session two and testing session three).  The dependent variables 
were scores on CNSVS (Neurocognitive Index, composite memory standard score, verbal 
memory standard score, visual memory standard score, processing speed standard score, 
executive function standard score, psychomotor speed standard score, reaction time standard 
score, complex attention standard score and cognitive flexibility standard score), the BESS 
(firm condition error score, foam condition error score and total error score) and the SAC 
(orientation, immediate memory, concentration, delayed  recall and SAC total score). 
Participants 
Participants in the study consisted of a convenience sample of thirty-four participants. 
Seventeen participants (nine males and eight females) were in the ADHD group (age: 
21.294±2.02, previous number of concussions: 0.647±0.702) and seventeen participants (nine 
males and eight females) were in the matched control group (age: 21.294±2.05, previous 
number of concussions: 0.647±0.702).  Participants in the control group were matched by 




in the ADHD group had to meet the following criteria: 1) declare that they have been 
diagnosed with ADHD, 2) complete an ADHD rating scale, adapted from part of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) to confirm they meet the 
ADHD criteria, 3) provide proof of a prescription for stimulant medication. The ADHD 
rating scale consists of a series of questions regarding inattentiveness and hyperactivity and  
has been used as a diagnostic criterion for ADHD.  Although, not commonly used in 
isolation, it identifies three separate sub-types of ADHD including inattentive, hyperactive 
and a combined type.  In order to participate each ADHD participant had to meet the criteria 
of one of the three sub-types.  All participants were physically active, defined as consistently 
participating in at least 30 minutes of cardiovascular and/or resistive training at least 4 times 
per week for the past five months.  Individuals reporting a history of three or more previous 
concussions, known vestibular dysfunction, or any lower extremity injury or concussion in 
the past six months were excluded from both groups.  
Instrumentation 
CNSVS (CNS Vital Signs, LLC, Chapel Hill, NC) consists of a series of 
computerized neurocognitive tests.  One of the purposes of CNSVS is to detect changes in 
neurocognitive performance over time, allowing for assistance in the evaluation of 
concussion.  Some advantages of CNSVS include millisecond timing, allowing for accurate 
detection of even small cognitive changes, immediate automated scoring, ease of exporting 
the scores and randomized presentation of data, allowing for long-term repeated 
administration of the test.  In addition, CNSVS allows for customized testing, meaning the 
test administrator can choose which tests to include in each evaluation. A multitude of 




cognitive dysfunction (Gualtieri, CT and Johnson, LG 2006).  Results include scores for the 
following clinical domains: neurocognitive index, composite memory, verbal memory, visual 
memory, processing speed, executive function, psychomotor speed, reaction time, complex 
attention and cognitive flexibility. Each participant was instructed to answer quickly while 
also trying to be correct, read all instructions, and to try to sustain their attention throughout 
the entire test. CNSVS has been shown to be both valid and reliable (Gualtieri, CT and 
Johnson, LG 2006).  All participants were administered the test in a quiet, controlled setting.  
The test took approximately 30 minutes for each participant to complete.   
The BESS is an objective assessment tool developed to assess postural stability 
following concussion.  It is portable, cost-effective and can be used in the absence of a more 
expensive or sophisticated tool (Guskiewicz 2003; Hunt, Ferrara et al. 2009).  It is also one 
of the most commonly used concussion assessment tools amongst athletic trainers (Ferrera et 
al., 2001).  The BESS involves three different stances (double leg, single leg and tandem 
stance) which are completed twice (once on a firm surface and once on an unstable surface), 
for a total of six twenty second trials (Guskiewicz 2003; Hunt, Ferrara et al. 2009). An Airex 
medium-density foam pad (20" L x 16.4" W x 2 1/2" H) (Power Systems Airex Balance Pad 
81000, Knoxville, TN) was used for the unstable surface.  The test took about five minutes to 
administer. All trials were videotaped and scored after testing to help ensure accuracy.  
Errors included lifting hands off iliac crests, opening eyes, stepping, stumbling or falling, 
moving the hip into greater than thirty degrees of flexion or abduction, forefoot or heel losing 
contact with the ground or remaining out of the testing position for more than five seconds 
(Riemann and Guskiewicz 2000).  Errors were recorded for each 20 second trial by the 




of all six trials.   The BESS has found to be both valid and reliable (Hunt et al., 2009; Barr et 
al., 2001; Broglio et al., 2009). 
The SAC is a paper-and-pencil test that is used to evaluate cognitive ability.  The 
SAC was designed in order to provide immediate information to athletic trainers and other 
medical providers regarding the management of head injuries.  Along with the BESS, the 
SAC is also one of the most commonly used concussion assessment tools amongst athletic 
trainers (Ferrara et al., 2001).  The SAC includes assessments of orientation, immediate 
recall, concentration, and delayed recall.  The SAC has been shown to be both valid and 
reliable in college athletes (McCrea, Kelly et al. 1997; Bleiberg, Kane et al. 2000; McCrea 
2001; Valovich, Perrin et al. 2003). Participants were administered a different form of the 
SAC containing new words lists and digit recall content at each testing session to minimize a 
practice effect.  The SAC was administered in a quiet, controlled environment.  Each test 
took about five minutes to administer.  
Testing Procedures 
Approval for the study and use of human subjects was granted by the university‘s 
institutional review board.  Participants reported to the University of North Carolina at 
Chapel Hill Matthew Gfeller Sport-Related Traumatic Brain Injury Research Center for 
testing. All participants were administered the CNSVS, BESS and SAC on three separate 
occasions, each seven to nine days apart. The testing order was counterbalanced between all 
participants and participants repeated the same test order at all three sessions.  Prior to data 
collection, all participants filled out a questionnaire to ensure that all inclusion and exclusion 




The control group was administered the CNSVS, BESS and SAC on three separate 
occasions, without any change in conditions.  For the participants in the ADHD group, the 
first two testing sessions were completed off medications (meaning they had not taken their 
medication for at least twenty-four hours prior to the testing session), while the third testing 
session was completed on medication (meaning they had taken their medication between one 
and three hours prior to the testing session). All three testing sessions for each participant 
occurred seven to nine days apart and were held at approximately the same time of day 
(within two hours of prior testing sessions).  For morning testing sessions, testing was 
completed prior to the participant‘s first class.  For evening testing sessions, testing was 
completed at least two hours after the conclusion of the participant‘s last class and the 
participant had three hours or less of classes on the testing day. Every effort was made to 
avoid disrupting the normal medication schedule of participants with ADHD.  A 
questionnaire was also administered to all participants prior to each testing session, which 
included information regarding hours of sleep, hydration and eating habits.  
Data Analysis 
 All data were analyzed using SPSS Version 17.0 (SPSS Inc, Chicago, Illinois).  An 
apriori alpha level was set at 0.05.  The effects of medication on scores of the ADHD group, 
relative to the control group, and differences in scores between the control group and the 
ADHD group while both on and off medication, were examined using separate 2 (group) x 2 
(session) mixed model repeated measures ANOVAs.  Tukey post-hoc was analyses were 
employed when the omnibus test for interaction effects were significant.  In addition, in order 
to examine the differences in practice effects between the control group and the ADHD 




measures ANOVAs were utilized.  Tukey post-hoc was analyses were employed when the 
omnibus test for interaction effects were significant.   
RESULTS 
The effects of stimulant medication 
 
 We examined the effects of stimulant medication in the ADHD group relative to 
matched controls on scores of concussion assessment tools comparing session one (ADHD-
off medication) to session three scores (ADHD-on medication). 
CNSVS 
 
 We did not observe any significant group x session interactions or main effects for 
scores on composite memory, verbal memory, visual memory, executive function, complex 
attention or cognitive flexibility.  The absence of an interaction effect, combined with an 
absence of any main effects may mean that there was no added effect of stimulant medication 
for these CNSVS subtests.   However, we observed a significant interaction effect for the 
neurocognitive index (F1,31=6.03, p=0.020).  Tukey post hoc analyses revealed that the 
ADHD group performed better on medication than off medication (dcrit=4.91).  We also 
noted a significant interaction effect for processing speed (F1,31=5.61, p=0.024) (Figure 4.5).  
Tukey post hoc analyses revealed that the ADHD group performed better on medication than 
off medication (dcrit=5.18).  Finally, we observed a significant interaction effect for 
psychomotor speed (F1,31=8.957, p=0.005) (Figure 4.7).  Once again, Tukey post hoc 





Balance Error Scoring System 
 
We did not observe any significant interaction effects for BESS total score.  
However, we did observe a significant session main effect (F1,32=5.17, p=0.030) (Figure 
4.11).  The ADHD and control group both performed better on the third testing session than 
they did on the second testing session.  Although the ADHD group performed better on their 
medication than off their medication, the control group improved between the second and 
third testing session as well.  This indicates that the increase in scores is likely due to a 
practice effect, as opposed to the medication.   
Standardized Assessment of Concussion 
 
 We did not observe any significant interaction effects for SAC total score.  However, 
we did observe a significant session main effect (F1,32=16.000, p<0.005).  The ADHD and 
control group both performed better on the third testing session than they did on the second 
testing session.  Although the ADHD group performed better on their medication than off 
their medication, the control group improved between the second and third testing session as 
well.  This indicates that the increase in scores is likely due to a practice effect, as opposed to 
the medication. 
Attention Deficit Hyperactivity Disorder (ADHD) compared to controls 
 
We examined the differences in scores on concussion assessment tools between the 
ADHD group when they were on their medication (session three) compared to matched 
controls.   We also examined the differences in scores on concussion assessment tools 
between the ADHD group when they were off their medication (session two) compared to 




to examine the effects of stimulant medication on concussion assessment tools was also used 
for this analysis. 
CNS Vital Signs 
 
As per above, we did not observe any significant group x session interactions or main 
effects for scores on composite memory, verbal memory, visual memory, executive 
function, complex attention or cognitive flexibility.  The absence of an interaction effect, 
combined with an absence of any main effects reflects that there was not a statistically 
significant difference between the two groups at session three on any of these subtests.  we 
observed a significant interaction effect for the neurocognitive index (F1,31=6.03, p=0.020) 
(Figure 4.1).  Tukey post hoc analyses revealed that the control group performed better than 
the ADHD group on the second testing session (dcrit=4.91).We also noted a significant 
interaction effect for processing speed (F1,31=5.61, p=0.024) (Figure 4.5).  Again, Tukey post 
hoc analyses revealed that the control group performed better than the ADHD group on the 
second testing session (dcrit=5.18).  Finally, we observed a significant interaction effect for 
psychomotor speed (F1,31=8.957, p=0.005) (Figure 4.7).  Once again, Tukey post hoc 
analyses revealed that the control group performed better than the ADHD group on the 
second testing session (dcrit=4.06).  However, post hoc analyses revealed no significant 
differences in scores between the ADHD and control group on the third testing session.   
Balance Error Scoring System 
 
 We did not observe any significant interaction or group main effects for the BESS 




main effects means that there not a statistically significant difference between the two groups 
at session three for the BESS.   
Standardized Assessment of Concussion 
 
 We did not observe any significant interaction or group main effects for the SAC total 
score. The absence of an interaction effect combined with the absence of any group main 
effects means that there is no statistically significant difference between the two groups at 
session three for the SAC.   
Practice Effects 
 
Separate 2x2 repeated measures ANOVAs were also utilized to evaluate the 
differences in practice effect between individuals with ADHD compared to matched controls 
on commonly used clinical concussion measures, including the CNSVS, the BESS and the 
SAC between an initial taking of the tests (session one- ADHD: off medication) and a second 
taking of the tests (session two- ADHD: off medication).   
CNS Vital Signs 
 
 We did not observe any significant group x session interactions or main effects for 
scores on verbal memory, visual memory, processing speed, psychomotor speed, or reaction 
time. We did observe a significant interaction effects on composite memory (F1,31=11.40, 
p=0.002) (Figure 4.14).  Tukey post hoc analysis revealed that the ADHD group performed 
better on their first testing session than they did on their second testing session (dcrit=6.37).  
In addition, we observed a significant session main effect for scores on the neurocognitive 
index (F1,31=7.85, p=0.009), executive function (F1,31=17.30, p<0.005), complex 




4.18 and 4.22).  In all cases, the scores of both the ADHD and control groups were higher on 
the second testing session, than on the first testing session, suggesting a significant practice 
effect existed for these subtests independent of group. 
Balance Error Scoring System 
 
We did not observe any significant group x session interactions or main effects for the 
BESS total score, suggesting there is no practice effect for either group 
 
Standardized Assessment of Concussion 
 We observed a significant group x session interaction effect for the SAC total score 
(F1,32=7.79, p=0.009)(Figure 4.24).  Tukey post hoc analyses revealed that the control group 
performed better on the first testing session than they did on the second testing session 
(dcrit=0.81), suggesting there is not a practice effect.  In addition, post hoc analyses revealed 
that the ADHD group performed statistically worse than the control group at both the first 
and second testing sessions, but closed the gap to some degree at the second session.  Thus, 
to no surprise the results revealed a main effect for group (F1,32=11.33, p=0.002), with the 
control group performing better than the ADHD group while off their medication. 
DISCUSSION 
The effect of ADHD on cognitive function has been widely researched; however the 
effect of ADHD on concussion measures is not as well understood. The most important result 
from our study is that individuals with ADHD perform better on select neurocognitive 
measures when on their prescribed stimulant medication.  The ADHD subjects in our study 
presented with better processing speed, psychomotor speed and overall neurocognitive 




by the ADHD group in the absence of any improvement in the control group rules out the 
possibility that the improvement was due to a practice effect between session two and three.  
The stimulant medication had a positive effect on these cognitive domains and should be an 
important consideration for clinicians when administering cognitive tests. 
Despite these improvements, there were no differences between the ADHD and 
control group on neurocognitive, balance or mental status performance as measured by the 
SAC when the ADHD group was on their medication (Research Question 2).  However, the 
control group performed better than the un-medicated ADHD group on processing speed, 
psychomotor speed, and overall neurocognitive performance (Research Question 3).  The 
ADHD group performed better on their first testing session than their second testing session 
on composite memory, while there was no change in scores in the control group.  
Conversely, the control group performed better on the first testing session on the SAC, while 
there was no difference in the ADHD group (Research Question 4). 
 
Effects of Stimulant Medications 
 
We observed a positive effect of medication on the neurocognitive index (NCI), 
processing speed and psychomotor speed portions of CNS Vital Signs, while we did not 
observe any effect of medication on composite memory, verbal memory, visual memory, 
executive function, reaction time, complex attention or cognitive flexibility.  In addition, the 
ADHD group improved on the BESS total score and SAC total score, when they were on 
their medication, compared to off medication.  However, the improved BESS and SAC total 




as well.  In addition, the change would likely not be considered clinically significant 
(changes of 1.42 and 1.00 respectively).   
We expected to see the medications have a positive effect on overall neurocognitive 
functioning by increasing arousal of the Central Nervous System (CNS).  The theory behind 
stimulant medications is that they increase arousal and alertness of the (CNS) through 
stimulation of norepinephrine and dopamine (Vaughan, et al.,  Volkow et al 1998, Bymaster 
et al. 2002 and Rowe et al.).  One study found that stimulants suppress the locus coeruleus, 
which reduces stimulation of the thalamic reticular nucleus, ultimately improving cortical 
arousal (Rowe et al).  Therefore, it is not surprising that the ADHD group improved on 
overall neurocognitive functioning while medicated.  In fact, a study by Riordan et al, also 
found that a stimulant medication improved overall performance on a battery of 
neuropsychological tests including measures of motor speed, processing speed and 
distractibility in an adult ADHD group (Riordan et al. 1999).  Furthermore, we expected to 
observe positive effects of medication on both the processing speed and psychomotor speed 
scores, because they are measures of attention and focused concentration (or distractibility) 
and stimulant medications have been shown to improve concentration and attention (Hickey 
1999). 
We expected to observe a positive effect of medication on all measures of CNSVS, but 
did not observe an effect of medication on measures of composite memory, verbal memory, 
visual memory, reaction time, complex attention or cognitive flexibility.  In addition, we 
expected to see a positive effect of medication on the BESS and SAC.  A probable reason the 
medication did affect many factors of the CNSVS, BESS or SAC is because the ADHD 




off their medication.  Although previous studies have found stimulant medications to have an 
effect on some of domains of CNS Vital Signs, it has also been observed that as individuals 
with ADHD age and mature, their test scores normalize (Gualtieri et al, etc.).  Therefore, a 
collegiate population who is likely to be intelligent and motivated and have their ADHD 
treatment under control is more likely to have normal neurocognitive, balance and mental 
status scores compared to an adolescent or child population.   
Our study suggests that although stimulant medication did not appear to improve 
balance or mental status, it did affect some neuropsychological components, including 
overall neurocognitive performance, processing speed and psychomotor speed.  Based on the 
results of our study, ADHD athletes should complete both their baseline and post-injury tests 
on their prescribed stimulant medications.  The majority of stimulant medications are 
prescribed to be taken on a daily basis. This study observed that when the ADHD participants 
were on their medication, there were no differences between their scores and the control 
group‘s scores.  However, when the ADHD group was off their medication, there were 
difference in neurocognitive performance, processing speed and psychomotor speed. 
In some cases, it may not be feasible for the individual to be on their medication for 
both the baseline and post injury testing.  For example, in some settings, it may be too 
difficult to notify all ADHD athletes who are prescribed a stimulant medication to make sure 
they take their medication prior to the testing session.  When this is the case, at the very 
minimum, the medication status of the athlete should be documented and held constant 
across sessions.  Questions such as: ―Have you ever been diagnosed with attentional deficit 
hyperactivity disorder (ADHD), attentional deficit disorder (ADD) or any other learning 




medication for the treatment of ADHD, ADD or other learning disability?‖, ―When did you 
first start taking the medication you are currently taking?‖, ―What type of medication are you 
on and what is your dose?‖, ―How often do you take your medication?‖, ―Do you think your 
medication works?‖ and ―How long has it been since you last took your prescribed 
medication?‖, should be added to the standard battery of concussion assessment tools.   This 
will allow for a better interpretation of post-injury scores. 
Attention Deficit Hyperactivity Disorder (ADHD) 
 
 We observed differences in scores on the NCI, processing speed and psychomotor 
speed portions of CNS Vital Signs between the control group and the ADHD group, when 
the ADHD group was off their medication.  On all three domains, the control group 
performed better than the ADHD group.  There was no significant difference between the 
groups on measures of balance or mental status.  While we initially hypothesized that the 
control group would perform better than the ADHD group on all measures of neurocognitive 
functioning, balance and mental status, it is fairly well supported that the ADHD group may 
not be impaired with certain types of memory, or balance.  Most studies that showed memory 
impairment within the ADHD population studied working memory (which involves retaining 
and manipulating information for several seconds), or recall memory, while CNS Vital Signs 
assesses recognition memory (Gropper and Tannock 2009; Valera, Brown et al. 2009).  It is 
likely that recognition memory is easier for the ADHD population and therefore they are able 
to perform similarly to a control group on the verbal and visual memory measures. 
However, it is interesting that there were no significant differences between the 
groups on measures of reaction time, complex attention and cognitive flexibility, because 




were not seen in this group, because individuals with ADHD who are able to perform 
academically at the collegiate level may have a milder form of the disorder (Wilmhurst L, et 
al 2009).  In addition, compared to the adolescent population, where the cognitive and 
balance deficits are typically seen, the collegiate population likely tends to be more mature 
and is more likely to have found the best treatment for their disorder.  It has been observed 
that individuals with ADHD experience a decrease in symptoms as they age (Hart et al. 
1995).  Since differences between the adolescent and adult ADHD population has been 
shown, it has even been suggested that age-specific assessments of ADHD should be 
considered (Ramtekkar et al. 2009).  Futhermore, a study by Schwartz et al. found that there 
was no difference between scores on Stroop interference tasks between an ADHD and age 
matched controls, and in our study the scores from the Stroop interference tasks make up part 
of the scores for reaction time, complex attention and cognitive flexibility scores (Schwartz 
K et al).    
Our study indicates that when ADHD individuals are on their stimulant medication, 
their scores are comparable to those of matched controls.  This provides an important 
implication for serial testing of ADHD athletes.  If individuals with ADHD are comparable 
to matched controls, when they are on their stimulant medications, then it is desirable that 
individuals with ADHD to take their stimulant medication prior to baseline and post-injury 
testing.  In the case where an athlete with ADHD sustains a concussion, but does not have a 
baseline measure, the team physician and athletic trainer should instruct the athlete to take 





Recent recommendations suggest that baseline testing on neurocognitive, postural 
control, and symptomotology measures be completed prior to sport exposure for all athletes, 
so that appropriate comparisons can be made post-injury. Our study suggests that both 
ADHD and stimulant medications affect scores on concussion assessment tools. Clinicians 
should make an effort to identify athletes with ADHD prior to concussion baseline evaluation 
and treat these athletes with special care to ensure quality baseline scores.  
Practice Effects 
 
A secondary aim of our study was to examine differences in practice effects between 
the control group and the ADHD group when they were off their medication.  We observed 
that the ADHD group performed better on the composite memory portion of CNSVS on their 
first testing session than their second testing session, while there was no significant 
difference between testing sessions in the control group.  Additionally, the control group 
performed better on the first testing session than on the second testing session for the SAC 
total score, while there was no significant difference between testing sessions in the ADHD 
group.  CNSVS has been shown to be both valid and reliable (Gualtieri et al. 2006).  
However, there may be differences in test-retest reliability between the ADHD and control 
population.  We hypothesized that the control group may benefit from a practice effect 
between the first and second testing session, while the ADHD group might not.  Our study 
suggests that the ADHD group declined in performance between the first and second testing 
session on the composite memory portion of CNSVS.  This could be due to the fact that the 
ADHD group performed better on the first testing session, due to the novelty effect, or the 
excitement associated with completing a task for the first time, while the task was not new 




attention for a long period of time (Poppenk 2010).  Composite memory was likely affected 
because the score is a combination of scores on both verbal and visual memory, in which 
tasks are repeated the end of the testing battery.  Therefore, they require attention over an 
extended period of time.   
Another interesting finding is that the control group had decreased scores between 
their first and second testing session on the SAC.  Although this finding was statistically 
significant, it is not clinically significant (difference of 1.00 point between testing sessions).  
McCrea et al. demonstrated that in a high school and collegiate sample of football players, 
the average change in scores from baseline to post injury was 3.50 (McCrea 1998).  In 
addition, studies in the high school population have found that there is generally no practice 
effect associated with the SAC (Valovich McLeod et al. 2004, McLeod et al. 2003).    
Although not part of the primary research questions, we did observe significant main 
effect of session on neurocognition index, executive function, complex attention and 
cognitive flexibility scores on CNSVS, with both groups scoring higher on the second testing 
session, than on the first testing session.  This suggests that there may be a practice effect in 
both the control and ADHD group on the neurocognition index, executive function, complex 
attention and cognitive flexibility portions of CNSVS when the test is re-administered with 
7-9 days of initial administration.  These results differ from the previous findings of Gualtieri 
et al; however, our study utilized a shorter time period between testing sessions (Gualtieri et 
al. 2006). 
It is important to continue examining differences in practice effects between the 
ADHD population both on and off medication and control group as these comparisons have 




and practice effects should be taken into account.  However, it is important to note that these 
reliable change indices and practice effects may be different in the ADHD population.  In 
addition, they could differ within the ADHD population, depending whether or not they are 
on or off medication.  Practice effects within the ADHD population needs to be examined in 
future studies. 
Limitations 
 We acknowledge there are some limitations with the procedures of this study.  This 
study only examined individuals with ADHD who were prescribed an immediate release 
stimulant medication for the treatment of ADHD.   Athlete‘s taking non-stimulant 
medications may respond differently than our sample of ADHD athletes.  Both the type and 
dose of medication could influence the effects of medication.  Also, the time since ADHD 
diagnosis, amount of time taking current prescribed stimulant medication and ADHD subtype 
could influence the scores on concussion assessment tools and the effects of the medication 
on scores. We attempted to control for these variables, by making sure that all ADHD 
participants had been previously diagnosed with ADHD and had taken their current stimulant 
medication for at least 6 months prior to their first testing session. Heterogeneity among the 
ADHD group may have limited our ability to identify significant differences across testing 
sessions. The ADHD group consisted of a relatively even distribution of ADHD subtypes 
(hyperactive, inattentive, and combined). ADHD individuals with different subtypes, 
although similar in many ways, experience different forms of the disorder. It seems possible, 
and likely, that ADHD individuals with different subtypes will present with different 
neurocognitive and postural control capabilities. Also, ADHD participants were diagnosed by 




diagnostic criteria could contribute to the heterogeneity of this group. Furthermore, the 
control group was not administered the ADHD rating scale to rule out the possibility of a 
missed ADHD diagnosis within the control group.  Another limitation is that information 
such as the diagnosis of ADHD and number of previous concussionswere self 
reported.However, ADHD participants did meet the criteria for diagnosis on the DSM-IV 
criteria and did present a prescription for a stimulant medication.  Additionally, the effect of 
stimulant medications in the ADHD group could have been mildly washed out by the 
practice effect between the second and third testing session.   Finally, this study could have 
benefitted from a larger sample size. We observed several low effect sizes for some 
dependent variables. This may have limited our ability to detect interaction effects between 
groups and sessions.  
 
Future Research 
 In the current study we only analyzed ADHD and control differences in postural 
control, neurocognition, and mental status in healthy physically active individuals. Graded 
symptom assessments are another integral piece to clinical concussion management. As part 
of our secondary analysis,we observed a significant interaction effect on the symptom scores 
(F(2,60)=40.310, p<0.005).  The ADHD group had a significantly higher score on the first 
testing session than the control group.  It is interesting that the ADHD group had 
significantly higher scores on the first testing session, but not the second testing session, 
considering they were off medication both times.  It is possible that the participants were not 
used to being off their medications, which caused them to experience symptoms for the first 




symptomatic and therefore, they did not report as severe symptoms.  The relationship 
between symptoms and scores on clinical measures of concussion, especially in the athletic 
ADHD population requires further research.   
 There are several other factors that could affect the scores of ADHD individuals on 
concussion assessment tools.  Therefore, future research should examine the influence of 
gender, type of medication and dose of medication on the effects of concussion assessment 
tools.  Several studies suggest that gender, type and dose of medication could play a role in 
the efficacy of stimulant medications used for the treatment of ADHD.  For example, a study 
by Swanson et al found that the optimal dose for cognitive effects was lower than that for 
behavioral effects, suggesting that different doses of medication could provide different 
benefits (Swanson 2011).   A future study could examine differences between two groups of 
ADHD individuals, one with a higher dose of medication and the other group with a lower 
dose of medication.  It is possible that the different groups would improve on different areas 
of the tests when they are on their medication.  In addition, future studies could examine the 
effect of ADHD subtype on scores of concussion assessment tools.   
 
Conclusions and Clinical Implications 
 Our findings are consistent with current findings that stimulant medications used to 
treat ADHD have been shown to have an effect on cognitive function (Agay 2010, Brams 
2010, Cornforth 2010).  Since stimulant medications have been shown to have an effect on 
scores on measures of concussion, clinicians should ensure that patients‘ baseline testing and 
post injury testing occurs under the same or similar medication statuses.  ADHD athletes 




medicine professionals should ensure that ADHD athletes complete concussion evaluation 
while on stimulant medication if comparing to normative data is necessary. There may be 
differences in practice effects between individuals with ADHD and the average population.  
This study found differences in practice effects on the composite memory and SAC total 
score. Our study suggests that it is especially important to obtain a baseline measure in 
individuals with ADHD, because it is difficult to compare scores to normative data. At the 
minimum, clinicians should note individuals with ADHD medication statuses upon baseline 
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